BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27-42. [PMID: 28506744 DOI: 10.1016/j.addr.2017.05.007] [Cited by in Crossref: 359] [Cited by in F6Publishing: 356] [Article Influence: 71.8] [Reference Citation Analysis]
Number Citing Articles
1 Golbabapour S, Bagheri-lankarani K, Ghavami S, Geramizadeh B. Autoimmune Hepatitis and Stellate Cells: An Insight into the Role of Autophagy. CMC 2020;27:6073-95. [DOI: 10.2174/0929867326666190402120231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Jiang H, Liu J, Zhang K, Zeng Q. Saikosaponin D Inhibits the Proliferation and Promotes the Apoptosis of Rat Hepatic Stellate Cells by Inducing Autophagosome Formation. Evid Based Complement Alternat Med 2021;2021:5451758. [PMID: 34457023 DOI: 10.1155/2021/5451758] [Reference Citation Analysis]
3 Elchaninov A, Vishnyakova P, Sukhikh G, Fatkhudinov T. Spleen: Reparative Regeneration and Influence on Liver. Life 2022;12:626. [DOI: 10.3390/life12050626] [Reference Citation Analysis]
4 Özel M, Baskol M, Akalın H, Baskol G. Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial-Mesenchymal Transition (EMT). Cell Biochem Biophys 2021;79:349-57. [PMID: 33689126 DOI: 10.1007/s12013-021-00974-1] [Reference Citation Analysis]
5 Tao Y, Tian K, Chen J, Tan D, Liu Y, Xiong Y, Chen Z, Tian Y. Network Pharmacology-Based Prediction of the Active Compounds, Potential Targets, and Signaling Pathways Involved in Danshiliuhao Granule for Treatment of Liver Fibrosis. Evid Based Complement Alternat Med 2019;2019:2630357. [PMID: 31354851 DOI: 10.1155/2019/2630357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Foglia B, Novo E, Protopapa F, Maggiora M, Bocca C, Cannito S, Parola M. Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis. Cells 2021;10:1764. [PMID: 34359934 DOI: 10.3390/cells10071764] [Reference Citation Analysis]
7 Keshavarz Azizi Raftar S, Abdollahiyan S, Azimirad M, Yadegar A, Vaziri F, Moshiri A, Siadat SD, Zali MR. The Anti-fibrotic Effects of Heat-Killed Akkermansia muciniphila MucT on Liver Fibrosis Markers and Activation of Hepatic Stellate Cells. Probiotics Antimicrob Proteins 2021;13:776-87. [PMID: 33433897 DOI: 10.1007/s12602-020-09733-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Cespiati A, Meroni M, Lombardi R, Oberti G, Dongiovanni P, Fracanzani AL. Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies. Biomedicines 2022;10:182. [DOI: 10.3390/biomedicines10010182] [Reference Citation Analysis]
9 He C, Shu B, Zhou Y, Zhang R, Yang X. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl4-induced hepatic fibrosis in mice. Life Sci 2021;276:119294. [PMID: 33675896 DOI: 10.1016/j.lfs.2021.119294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hu Q, Liu M, You Y, Zhou G, Chen Y, Yuan H, Xie L, Han S, Zhu K. Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis. Free Radic Biol Med 2021;175:193-205. [PMID: 34492311 DOI: 10.1016/j.freeradbiomed.2021.08.241] [Reference Citation Analysis]
11 Sepulveda-Crespo D, Resino S, Martinez I. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021;81:419-43. [PMID: 33400242 DOI: 10.1007/s40265-020-01458-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Gough A, Soto-Gutierrez A, Vernetti L, Ebrahimkhani MR, Stern AM, Taylor DL. Human biomimetic liver microphysiology systems in drug development and precision medicine. Nat Rev Gastroenterol Hepatol 2021;18:252-68. [PMID: 33335282 DOI: 10.1038/s41575-020-00386-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
13 Chale-Dzul J, Pérez-Cabeza de Vaca R, Quintal-Novelo C, Olivera-Castillo L, Moo-Puc R. Hepatoprotective effect of a fucoidan extract from Sargassum fluitans Borgesen against CCl4-induced toxicity in rats. Int J Biol Macromol 2020;145:500-9. [PMID: 31874267 DOI: 10.1016/j.ijbiomac.2019.12.183] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
14 Fan QQ, Zhang CL, Qiao JB, Cui PF, Xing L, Oh YK, Jiang HL. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy. Biomaterials 2020;230:119616. [PMID: 31837823 DOI: 10.1016/j.biomaterials.2019.119616] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
15 Di J, Gao X, Du Y, Zhang H, Gao J, Zheng A. Size, shape, charge and “stealthy” surface: Carrier properties affect the drug circulation time in vivo. Asian Journal of Pharmaceutical Sciences 2020. [DOI: 10.1016/j.ajps.2020.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Mastoridou EM, Goussia AC, Glantzounis GK, Kanavaros P, Charchanti AV. Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis. Front Physiol 2022;12:801340. [DOI: 10.3389/fphys.2021.801340] [Reference Citation Analysis]
17 Hall KC, Bernier SG, Jacobson S, Liu G, Zhang PY, Sarno R, Catanzano V, Currie MG, Masferrer JL. sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH. Proc Natl Acad Sci U S A 2019;116:11057-62. [PMID: 31085647 DOI: 10.1073/pnas.1821045116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
18 Fujiwara N, Liu P, Athuluri-divakar SK, Zhu S, Hoshida Y. Risk Factors of Hepatocellular Carcinoma for Precision Personalized Care. In: Hoshida Y, editor. Hepatocellular Carcinoma. Cham: Springer International Publishing; 2019. pp. 3-25. [DOI: 10.1007/978-3-030-21540-8_1] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chen P, Luo X, Dai G, Jiang Y, Luo Y, Peng S, Wang H, Xie P, Qu C, Lin W, Hong J, Ning X, Li A. Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation. Exp Mol Med 2020;52:1062-74. [PMID: 32632241 DOI: 10.1038/s12276-020-0461-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Pu S, Zhou H, Liu Y, Liu J, Guo Y, Zhou H. Roles of nuclear receptors in hepatic stellate cells. Expert Rev Gastroenterol Hepatol 2021;15:879-90. [PMID: 34225534 DOI: 10.1080/17474124.2021.1949288] [Reference Citation Analysis]
21 Lv S, Yu H, Liu X, Gao X. The Study on the Mechanism of Hugan Tablets in Treating Drug-Induced Liver Injury Induced by Atorvastatin. Front Pharmacol 2021;12:683707. [PMID: 34262454 DOI: 10.3389/fphar.2021.683707] [Reference Citation Analysis]
22 Ezhilarasan D. Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis. J Cell Physiol 2021. [PMID: 34514599 DOI: 10.1002/jcp.30582] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 da Silva Meirelles L, Marson RF, Solari MIG, Nardi NB. Are Liver Pericytes Just Precursors of Myofibroblasts in Hepatic Diseases? Insights from the Crosstalk between Perivascular and Inflammatory Cells in Liver Injury and Repair. Cells 2020;9:E188. [PMID: 31940814 DOI: 10.3390/cells9010188] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
24 Wang Y, Gao R, Li J, Tang S, Li S, Tong Q, Li S. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization. Int J Nanomedicine 2021;16:2803-18. [PMID: 33880025 DOI: 10.2147/IJN.S284560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ji D, Chen GF, Wang JC, Ji SH, Wu XW, Lu XJ, Chen JL, Li JT. Hsa_circ_0070963 inhibits liver fibrosis via regulation of miR-223-3p and LEMD3. Aging (Albany NY) 2020;12:1643-55. [PMID: 32003753 DOI: 10.18632/aging.102705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
26 Zhou M, Zhao X, Huang T, Zou G, Hu R, Cheng M. PFKFB3 Promotes Liver Fibrosis by Regulating Aerobic Glycolysis of Hepatic Stellate Cells. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.113968] [Reference Citation Analysis]
27 Zhang Q, Shen F, Shen W, Xia J, Wang J, Zhao Y, Zhang Z, Sun Y, Qian M, Ding S. High-Intensity Interval Training Attenuates Ketogenic Diet-Induced Liver Fibrosis in Type 2 Diabetic Mice by Ameliorating TGF-β1/Smad Signaling. Diabetes Metab Syndr Obes 2020;13:4209-19. [PMID: 33192083 DOI: 10.2147/DMSO.S275660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Li G, Jiang Q, Xu K. CREB family: A significant role in liver fibrosis. Biochimie 2019;163:94-100. [PMID: 31112743 DOI: 10.1016/j.biochi.2019.05.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
29 Sun S, Huan S, Li Z, Yao Y, Su Y, Xia S, Wang S, Xu X, Shao J, Zhang Z, Zhang F, Fu J, Zheng S. Curcumol alleviates liver fibrosis by inducing endoplasmic reticulum stress-mediated necroptosis of hepatic stellate cells through Sirt1/NICD pathway. PeerJ 2022;10:e13376. [DOI: 10.7717/peerj.13376] [Reference Citation Analysis]
30 Doherty Lyons S, Blum JL, Hoffman-Budde C, Tijerina PB, Fiel MI, J Conklin D, Gany F, Odin JA, Zelikoff JT. Prenatal Exposure to Gutkha, a Globally Relevant Smokeless Tobacco Product, Induces Hepatic Changes in Adult Mice. Int J Environ Res Public Health 2020;17:E7895. [PMID: 33126512 DOI: 10.3390/ijerph17217895] [Reference Citation Analysis]
31 Pennisi G, Celsa C, Giammanco A, Spatola F, Petta S. The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives. Int J Mol Sci 2019;20:E5613. [PMID: 31717576 DOI: 10.3390/ijms20225613] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
32 Zhang WJ, Chen SJ, Zhou SC, Wu SZ, Wang H. Inflammasomes and Fibrosis. Front Immunol 2021;12:643149. [PMID: 34177893 DOI: 10.3389/fimmu.2021.643149] [Reference Citation Analysis]
33 Dawood RM, El-meguid MA, Salum GM, El Awady MK. Key Players of Hepatic Fibrosis. Journal of Interferon & Cytokine Research 2020;40:472-89. [DOI: 10.1089/jir.2020.0059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 An SY, Petrescu AD, DeMorrow S. Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis. Front Pharmacol 2021;12:645703. [PMID: 33841164 DOI: 10.3389/fphar.2021.645703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wang L, Wang Y, Quan J. Exosomal miR-223 derived from natural killer cells inhibits hepatic stellate cell activation by suppressing autophagy. Mol Med. 2020;26:81. [PMID: 32873229 DOI: 10.1186/s10020-020-00207-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Hernández A, Arab JP, Reyes D, Lapitz A, Moshage H, Bañales JM, Arrese M. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy. Cells 2020;9:E817. [PMID: 32231001 DOI: 10.3390/cells9040817] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
37 Rada M, Lazaris A, Kapelanski-Lamoureux A, Mayer TZ, Metrakos P. Tumor microenvironment conditions that favor vessel co-option in colorectal cancer liver metastases: A theoretical model. Semin Cancer Biol 2021;71:52-64. [PMID: 32920126 DOI: 10.1016/j.semcancer.2020.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 da Silva CM, Caetano FH, Pereira FDC, Morales MAM, Sakane KK, Moraes KCM. Cellular and molecular effects of Baccharis dracunculifolia D.C. and Plectranthus barbatus Andrews medicinal plant extracts on retinoid metabolism in the human hepatic stellate cell LX-2. BMC Complement Altern Med 2019;19:222. [PMID: 31438947 DOI: 10.1186/s12906-019-2591-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Fujita K, Masaki T. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept "Compensated Advanced Chronic Liver Disease". J Clin Med 2021;10:3340. [PMID: 34362121 DOI: 10.3390/jcm10153340] [Reference Citation Analysis]
40 Xu L, Yang C, Ma J, Zhang X, Wang Q, Xiong X. NAMPT-mediated NAD+ biosynthesis suppresses activation of hepatic stellate cells and protects against CCl4-induced liver fibrosis in mice. Hum Exp Toxicol 2021;40:S666-75. [PMID: 34752167 DOI: 10.1177/09603271211052991] [Reference Citation Analysis]
41 Yin F, Wang WY, Jiang WH. Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: From biological characteristics to therapeutic mechanisms. World J Stem Cells 2019; 11(8): 548-564 [PMID: 31523373 DOI: 10.4252/wjsc.v11.i8.548] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
42 Song Z, Liu X, Zhang W, Luo Y, Xiao H, Liu Y, Dai G, Hong J, Li A. Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2. J Transl Med 2022;20:157. [PMID: 35382859 DOI: 10.1186/s12967-022-03366-y] [Reference Citation Analysis]
43 da Silva Morais A, Oliveira JM, Reis RL. Biomaterials and Microfluidics for Liver Models. In: Oliveira JM, Reis RL, editors. Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models. Cham: Springer International Publishing; 2020. pp. 65-86. [DOI: 10.1007/978-3-030-36588-2_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Guan Y, Enejder A, Wang M, Fang Z, Cui L, Chen SY, Wang J, Tan Y, Wu M, Chen X, Johansson PK, Osman I, Kunimoto K, Russo P, Heilshorn SC, Peltz G. A human multi-lineage hepatic organoid model for liver fibrosis. Nat Commun 2021;12:6138. [PMID: 34686668 DOI: 10.1038/s41467-021-26410-9] [Reference Citation Analysis]
45 Hamada-Tsutsumi S, Onishi M, Matsuura K, Isogawa M, Kawashima K, Sato Y, Tanaka Y. Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture. Int J Mol Sci 2020;21:E7251. [PMID: 33019495 DOI: 10.3390/ijms21197251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Salhab A, Amer J, Lu Y, Safadi R. Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis. Gut 2021:gutjnl-2020-323345. [PMID: 34266968 DOI: 10.1136/gutjnl-2020-323345] [Reference Citation Analysis]
47 Elchaninov AV, Fatkhudinov TK, Vishnyakova PA, Lokhonina AV, Sukhikh GT. Phenotypical and Functional Polymorphism of Liver Resident Macrophages. Cells 2019;8:E1032. [PMID: 31491903 DOI: 10.3390/cells8091032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
48 Ma Y, Li Y, Zhang H, Wang Y, Wu C, Huang W. Malvidin induces hepatic stellate cell apoptosis via the endoplasmic reticulum stress pathway and mitochondrial pathway. Food Sci Nutr 2020;8:5095-106. [PMID: 32994970 DOI: 10.1002/fsn3.1810] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Tan Y, Li Y, Zhou F, Guo J, Wang T, Shi Y, Yang Y, Lu J, Pei G. Administration of a mixture of triterpenoids from yeyachun and phenolic acids from danshen ameliorates carbon tetrachloride-induced liver fibrosis in mice by the regulation of intestinal flora. Journal of Pharmacological Sciences 2020;143:165-75. [DOI: 10.1016/j.jphs.2020.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Ma L, Wei J, Zeng Y, Liu J, Xiao E, Kang Y, Kang Y. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis. Drug Deliv 2022;29:440-53. [PMID: 35099348 DOI: 10.1080/10717544.2022.2030428] [Reference Citation Analysis]
51 Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Current treatment paradigms and emerging therapies for NAFLD/NASH. Front Biosci (Landmark Ed) 2021;26:206-37. [PMID: 33049668 DOI: 10.2741/4892] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
52 Sun X, Harris EN. New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease. Am J Physiol Cell Physiol 2020;318:C1200-13. [PMID: 32374676 DOI: 10.1152/ajpcell.00062.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
53 Chen TT, Xiao F, Li N, Shan S, Qi M, Wang ZY, Zhang SN, Wei W, Sun WY. Inflammasome as an Effective Platform for Fibrosis Therapy. J Inflamm Res 2021;14:1575-90. [PMID: 33907438 DOI: 10.2147/JIR.S304180] [Reference Citation Analysis]
54 Prakash J, Pinzani M. Fibroblasts and extracellular matrix: Targeting and therapeutic tools in fibrosis and cancer. Adv Drug Deliv Rev. 2017;121:1-2. [PMID: 29191284 DOI: 10.1016/j.addr.2017.11.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
55 Yang J, Liu Q, Cao S, Xu T, Li X, Zhou D, Pan L, Li C, Huang C, Meng X, Zhang L, Wang X. MicroRNA-145 Increases the Apoptosis of Activated Hepatic Stellate Cells Induced by TRAIL through NF-κB Signaling Pathway. Front Pharmacol 2017;8:980. [PMID: 29375381 DOI: 10.3389/fphar.2017.00980] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
56 Arif E, Wang C, Swiderska-Syn MK, Solanki AK, Rahman B, Manka PP, Coombes JD, Canbay A, Papa S, Nihalani D, Aspichueta P, Lipschutz JH, Syn WK. Targeting myosin 1c inhibits murine hepatic fibrogenesis. Am J Physiol Gastrointest Liver Physiol 2021;320:G1044-53. [PMID: 33908271 DOI: 10.1152/ajpgi.00105.2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Montaldo C, Terri M, Riccioni V, Battistelli C, Bordoni V, D'Offizi G, Prado MG, Trionfetti F, Vescovo T, Tartaglia E, Strippoli R, Agrati C, Tripodi M. Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response. J Hepatol 2021:S0168-8278(21)01901-2. [PMID: 34271004 DOI: 10.1016/j.jhep.2021.07.003] [Reference Citation Analysis]
58 Morsy MA, Nair AB. Prevention of rat liver fibrosis by selective targeting of hepatic stellate cells using hesperidin carriers. International Journal of Pharmaceutics 2018;552:241-50. [DOI: 10.1016/j.ijpharm.2018.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
59 Al Mamun A, Wu Y, Jia C, Munir F, Sathy KJ, Sarker T, Monalisa I, Zhou K, Xiao J. Role of pyroptosis in liver diseases. Int Immunopharmacol 2020;84:106489. [PMID: 32304992 DOI: 10.1016/j.intimp.2020.106489] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
60 Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol 2019;70:294-304. [PMID: 30658730 DOI: 10.1016/j.jhep.2018.12.003] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 30.5] [Reference Citation Analysis]
61 Zong Z, Liu J, Wang N, Yang C, Wang Q, Zhang W, Chen Y, Liu X, Deng H. Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE2 degradation. Free Radic Biol Med 2021;162:571-81. [PMID: 33220424 DOI: 10.1016/j.freeradbiomed.2020.11.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
62 Wu S, Liu L, Yang S, Kuang G, Yin X, Wang Y, Xu F, Xiong L, Zhang M, Wan J, Gong X. Paeonol alleviates CCl4-induced liver fibrosis through suppression of hepatic stellate cells activation via inhibiting the TGF-β/Smad3 signaling. Immunopharmacol Immunotoxicol 2019;41:438-45. [PMID: 31119954 DOI: 10.1080/08923973.2019.1613427] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
63 de Moraes ACN, de Andrade CBV, Ramos IPR, Dias ML, Batista CMP, Pimentel CF, de Carvalho JJ, Goldenberg RCDS. Resveratrol promotes liver regeneration in drug-induced liver disease in mice. Food Res Int 2021;142:110185. [PMID: 33773662 DOI: 10.1016/j.foodres.2021.110185] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Sasson A, Kristoferson E, Batista R, McClung JA, Abraham NG, Peterson SJ. The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD. Arch Biochem Biophys 2021;697:108679. [PMID: 33248947 DOI: 10.1016/j.abb.2020.108679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Yang Y, Min Z. Effect of long non‑coding RNA AK021443 on promoting hepatic fibrosis in vitro. Mol Med Rep 2021;23:196. [PMID: 33495828 DOI: 10.3892/mmr.2021.11835] [Reference Citation Analysis]
66 Yang Y, Zhao Y, Zhang L, Zhang F, Li L. The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues. Front Med (Lausanne) 2021;8:655268. [PMID: 34136500 DOI: 10.3389/fmed.2021.655268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Li Y, Pu S, Liu Q, Li R, Zhang J, Wu T, Chen L, Li H, Yang X, Zou M, Xiao J, Xie W, He J. An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis. J Control Release 2019;303:77-90. [PMID: 31004666 DOI: 10.1016/j.jconrel.2019.04.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
68 Bian M, He J, Jin H, Lian N, Shao J, Guo Q, Wang S, Zhang F, Zheng S. Oroxylin A induces apoptosis of activated hepatic stellate cells through endoplasmic reticulum stress. Apoptosis 2019;24:905-20. [DOI: 10.1007/s10495-019-01568-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
69 Zheng G, Liu J, Yan Guo F, Zhang Z, Jiang Y, Lin Y, Lan X, Ren J, Wu Y, Nan J, Hua Jin C, Lian L. The in vitro and in vivo study of a pyrazole derivative, J-1063, as a novel anti-liver fibrosis agent: Synthesis, biological evaluation, and mechanistic analysis. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105715] [Reference Citation Analysis]
70 Li Q, Ding Y, Guo X, Luo S, Zhuang H, Zhou J, Xu N, Yan Z. Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo. J Cell Mol Med 2019;23:1951-62. [PMID: 30592139 DOI: 10.1111/jcmm.14097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
71 Wang Z, Li J, Xiao W, Long J, Zhang H. The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis. Lab Invest 2018;98:1600-13. [DOI: 10.1038/s41374-018-0127-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
72 Novo E, Bocca C, Foglia B, Protopapa F, Maggiora M, Parola M, Cannito S. Liver fibrogenesis: un update on established and emerging basic concepts. Arch Biochem Biophys 2020;689:108445. [PMID: 32524998 DOI: 10.1016/j.abb.2020.108445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
73 Cairo MS, Cooke KR, Lazarus HM, Chao N. Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation. Br J Haematol 2020;190:822-36. [PMID: 32133623 DOI: 10.1111/bjh.16557] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
74 Demirel-Yalciner T, Sozen E, Ozaltin E, Sahin A, Ozer NK. alpha-Tocopherol supplementation reduces inflammation and apoptosis in high cholesterol mediated nonalcoholic steatohepatitis. Biofactors 2021;47:403-13. [PMID: 34101924 DOI: 10.1002/biof.1700] [Reference Citation Analysis]
75 Ezhilarasan D. Mitochondria: A critical hub for hepatic stellate cells activation during chronic liver diseases. Hepatobiliary Pancreat Dis Int 2021;20:315-22. [PMID: 33975780 DOI: 10.1016/j.hbpd.2021.04.010] [Reference Citation Analysis]
76 Li J, Tuo B. Current and Emerging Approaches for Hepatic Fibrosis Treatment. Gastroenterol Res Pract 2021;2021:6612892. [PMID: 34326871 DOI: 10.1155/2021/6612892] [Reference Citation Analysis]
77 Liang B, Gao L, Wang F, Li Z, Li Y, Tan S, Chen A, Shao J, Zhang Z, Sun L, Zhang F, Zheng S. The mechanism research on the anti-liver fibrosis of emodin based on network pharmacology. IUBMB Life 2021;73:1166-79. [PMID: 34173707 DOI: 10.1002/iub.2523] [Reference Citation Analysis]
78 Cheng Q, Qin W, Yu Y, Li G, Wu J, Zhuo L, Bououdina M. Preparation and Characterization of PEG-PLA Genistein Micelles Using a Modified Emulsion-Evaporation Method. Journal of Nanomaterials 2020;2020:1-15. [DOI: 10.1155/2020/3278098] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Weber F, Casalini T, Valentino G, Brülisauer L, Andreas N, Koeberle A, Kamradt T, Contini A, Luciani P. Targeting transdifferentiated hepatic stellate cells and monitoring the hepatic fibrogenic process by means of IGF2R-specific peptides designed in silico. J Mater Chem B 2021;9:2092-106. [PMID: 33595041 DOI: 10.1039/d0tb02372h] [Reference Citation Analysis]
80 Martin-Grau M, Marrachelli VG, Monleon D. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn? World J Hepatol 2022; 14(2): 304-318 [DOI: 10.4254/wjh.v14.i2.304] [Reference Citation Analysis]
81 Li H. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula. J Ethnopharmacol 2020;251:112442. [PMID: 31891799 DOI: 10.1016/j.jep.2019.112442] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
82 Qiao J, Fan Q, Xing L, Cui P, He Y, Zhu J, Wang L, Pang T, Oh Y, Zhang C, Jiang H. Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis. Journal of Controlled Release 2018;283:113-25. [DOI: 10.1016/j.jconrel.2018.05.032] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
83 Srivastava RAK. Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. J Diabetes Metab Disord 2018;17:381-91. [PMID: 30918873 DOI: 10.1007/s40200-018-0378-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
84 Ren R, Wang Z, Wu M, Wang H. Emerging Roles of SIRT1 in Alcoholic Liver Disease. Int J Biol Sci 2020;16:3174-83. [PMID: 33162823 DOI: 10.7150/ijbs.49535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Yan Y, Zeng J, Xing L, Li C. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation. Biomedicines 2021;9:1014. [PMID: 34440218 DOI: 10.3390/biomedicines9081014] [Reference Citation Analysis]
86 Dallio M, Romeo M, Gravina AG, Masarone M, Larussa T, Abenavoli L, Persico M, Loguercio C, Federico A. Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives. Nutrients 2021;13:1679. [PMID: 34063372 DOI: 10.3390/nu13051679] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Yang G, Zhan J, Yang Y, Yuan L, Wang P, Ho C, Li S. Inhibitory effects of oxyresveratrol on ERK and Smad1/2 phosphorylation and HSC activation in preventing carbon tetrachloride-induced rat liver fibrosis. Food Science and Human Wellness 2021;10:6-12. [DOI: 10.1016/j.fshw.2020.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Chan YT, Wang N, Tan HY, Li S, Feng Y. Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era? Front Pharmacol 2020;11:548. [PMID: 32425789 DOI: 10.3389/fphar.2020.00548] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
89 Keane JT, Elangovan H, Stokes RA, Gunton JE. Vitamin D and the Liver-Correlation or Cause? Nutrients 2018;10:E496. [PMID: 29659559 DOI: 10.3390/nu10040496] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
90 Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol 2018;68:526-49. [PMID: 28989095 DOI: 10.1016/j.jhep.2017.09.016] [Cited by in Crossref: 198] [Cited by in F6Publishing: 196] [Article Influence: 39.6] [Reference Citation Analysis]
91 Thompson WL, Takebe T. Generation of multi-cellular human liver organoids from pluripotent stem cells. Methods Cell Biol 2020;159:47-68. [PMID: 32586449 DOI: 10.1016/bs.mcb.2020.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Bauer B, Mally A, Liedtke D. Zebrafish Embryos and Larvae as Alternative Animal Models for Toxicity Testing. Int J Mol Sci 2021;22:13417. [PMID: 34948215 DOI: 10.3390/ijms222413417] [Reference Citation Analysis]
93 Kobayashi T, Kanno K, Nguyen PT, Sugiyama A, Kawahara A, Otani Y, Kishikawa N, Ito M, Tazuma S. Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2020;35:2140-50. [PMID: 32365405 DOI: 10.1111/jgh.15088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
94 Tee JK, Ng LY, Koh HY, Leong DT, Ho HK. Titanium Dioxide Nanoparticles Enhance Leakiness and Drug Permeability in Primary Human Hepatic Sinusoidal Endothelial Cells. Int J Mol Sci 2018;20:E35. [PMID: 30577655 DOI: 10.3390/ijms20010035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
95 Monroy-Ramirez HC, Galicia-Moreno M, Sandoval-Rodriguez A, Meza-Rios A, Santos A, Armendariz-Borunda J. PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases. Int J Mol Sci 2021;22:8298. [PMID: 34361064 DOI: 10.3390/ijms22158298] [Reference Citation Analysis]
96 Dmello RS, To SQ, Chand AL. Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer. Int J Mol Sci 2021;22:2067. [PMID: 33669775 DOI: 10.3390/ijms22042067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Liu XY, Li D, Li TY, Wu Y, Piao JS, Piao MG. Vitamin A - modified Betulin polymer micelles with hepatic targeting capability for hepatic fibrosis protection. European Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ejps.2022.106189] [Reference Citation Analysis]
98 Casas-Grajales S, Reyes-Gordillo K, Cerda-García-Rojas CM, Tsutsumi V, Lakshman MR, Muriel P. Rebaudioside A administration prevents experimental liver fibrosis: an in vivo and in vitro study of the mechanisms of action involved. J Appl Toxicol 2019;39:1118-31. [PMID: 30883860 DOI: 10.1002/jat.3797] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
99 Kühnl J, Tao TP, Brandmair K, Gerlach S, Rings T, Müller-Vieira U, Przibilla J, Genies C, Jaques-Jamin C, Schepky A, Marx U, Hewitt NJ, Maschmeyer I. Characterization of application scenario-dependent pharmacokinetics and pharmacodynamic properties of permethrin and hyperforin in a dynamic skin and liver multi-organ-chip model. Toxicology 2021;448:152637. [PMID: 33220337 DOI: 10.1016/j.tox.2020.152637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
100 Hou W, Syn WK. Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis. Front Cell Dev Biol. 2018;6:150. [PMID: 30483502 DOI: 10.3389/fcell.2018.00150] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
101 Alkhouri N, Gawrieh S. A perspective on RNA interference-based therapeutics for metabolic liver diseases. Expert Opin Investig Drugs 2021;30:237-44. [PMID: 33470860 DOI: 10.1080/13543784.2021.1879792] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Li H. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma. Expert Rev Gastroenterol Hepatol 2021;15:217-33. [PMID: 33131349 DOI: 10.1080/17474124.2021.1842732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Tabernilla A, Dos Santos Rodrigues B, Pieters A, Caufriez A, Leroy K, Van Campenhout R, Cooreman A, Gomes AR, Arnesdotter E, Gijbels E, Vinken M. In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach. Int J Mol Sci 2021;22:5038. [PMID: 34068678 DOI: 10.3390/ijms22095038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Szafranska K, Kruse LD, Holte CF, McCourt P, Zapotoczny B. The wHole Story About Fenestrations in LSEC. Front Physiol 2021;12:735573. [PMID: 34588998 DOI: 10.3389/fphys.2021.735573] [Reference Citation Analysis]
105 Wang Y, Chen B, Xiao C, Yu J, Bu X, Jiang F, Ding W, Ge Z. Effect of miR-183-5p on Cholestatic Liver Fibrosis by Regulating Fork Head Box Protein O1 Expression. Front Physiol 2021;12:737313. [PMID: 34867446 DOI: 10.3389/fphys.2021.737313] [Reference Citation Analysis]
106 Huang YJ, Cao J, Lee CY, Wu YM. Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis. Stem Cell Res Ther 2021;12:568. [PMID: 34772443 DOI: 10.1186/s13287-021-02641-x] [Reference Citation Analysis]
107 Li C, Tan YH, Sun J, Deng FM, Liu YL. PAX6 contributes to the activation and proliferation of hepatic stellate cells via activating Hedgehog/GLI1 pathway. Biochem Biophys Res Commun 2020;526:314-20. [PMID: 32209258 DOI: 10.1016/j.bbrc.2020.03.086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Jia Z, Zhao C, Wang M, Zhao X, Zhang W, Han T, Xia Q, Han Z, Lin R, Li X. Hepatotoxicity assessment of Rhizoma Paridis in adult zebrafish through proteomes and metabolome. Biomedicine & Pharmacotherapy 2020;121:109558. [DOI: 10.1016/j.biopha.2019.109558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
109 Deshmukh M, Nakagawa S, Higashi T, Vincek A, Venkatesh A, Ruiz de Galarreta M, Koh AP, Goossens N, Hirschfield H, Bian CB, Fujiwara N, Ono A, Hoshida H, El-Abtah M, Ahmad NB, Lujambio A, Sanchez R, Fuchs BC, Poelstra K, Prakash J, Hoshida Y; Precision Liver Cancer Prevention Consortium. Cell type-specific pharmacological kinase inhibition for cancer chemoprevention. Nanomedicine 2018;14:317-25. [PMID: 29157977 DOI: 10.1016/j.nano.2017.11.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
110 Radwan SAA, El-Maadawy WH, Yousry C, ElMeshad AN, Shoukri RA. Zein/Phospholipid Composite Nanoparticles for Successful Delivery of Gallic Acid into aHSCs: Influence of Size, Surface Charge, and Vitamin A Coupling. Int J Nanomedicine 2020;15:7995-8018. [PMID: 33116514 DOI: 10.2147/IJN.S270242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
111 Hamza AA, Lashin FM, Gamel M, Hassanin SO, Abdalla Y, Amin A. Hawthorn Herbal Preparation from Crataegus oxyacantha Attenuates In Vivo Carbon Tetrachloride -Induced Hepatic Fibrosis via Modulating Oxidative Stress and Inflammation. Antioxidants (Basel) 2020;9:E1173. [PMID: 33255507 DOI: 10.3390/antiox9121173] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
112 Gao H, Wen N, Xu X, Hong G, Lai X. [Endoplasmic reticulum stress enhances tumor necrosis factor-α expression in rat Kupffer cells to trigger hepatic stellate apoptosis cell through TNFR/caspase-8 pathway]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:632-9. [PMID: 32897203 DOI: 10.12122/j.issn.1673-4254.2020.05.04] [Reference Citation Analysis]
113 Aishwarya V, Solaipriya S, Sivaramakrishnan V. Role of ellagic acid for the prevention and treatment of liver diseases. Phytother Res 2021;35:2925-44. [PMID: 33368795 DOI: 10.1002/ptr.7001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Zhang B, Lapenta K, Wang Q, Nam JH, Chung D, Robert ME, Nathanson MH, Yang X. Trefoil factor 2 secreted from damaged hepatocytes activates hepatic stellate cells to induce fibrogenesis. J Biol Chem 2021;297:100887. [PMID: 34146542 DOI: 10.1016/j.jbc.2021.100887] [Reference Citation Analysis]
115 Wang K, Wang J, Song M, Wang H, Xia N, Zhang Y. Angelica sinensis polysaccharide attenuates CCl4-induced liver fibrosis via the IL-22/STAT3 pathway. Int J Biol Macromol 2020;162:273-83. [PMID: 32569681 DOI: 10.1016/j.ijbiomac.2020.06.166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
116 Qiu C, Liu Y, Huang S, Ning B, He S, Zhong L. Rab31 Promotes Activation of Hepatic Stellate Cells by Accelerating TGF-β Receptor II Complex Endocytosis. The International Journal of Biochemistry & Cell Biology 2022. [DOI: 10.1016/j.biocel.2022.106170] [Reference Citation Analysis]
117 Yang S, Cheng J, Zhang R, Sun H, Zhang H, Lyu S, Duan W. Metabolic dysfunction-associated fatty liver disease and liver fibrosis: Prevalence and associated factors in the middle-aged and older US population. Hepatol Res 2021. [PMID: 34751487 DOI: 10.1111/hepr.13728] [Reference Citation Analysis]
118 Duspara K, Bojanic K, Pejic JI, Kuna L, Kolaric TO, Nincevic V, Smolic R, Vcev A, Glasnovic M, Curcic IB, Smolic M. Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update. J Clin Transl Hepatol 2021;9:960-71. [PMID: 34966659 DOI: 10.14218/JCTH.2021.00065] [Reference Citation Analysis]
119 Bu FT, Chen Y, Yu HX, Chen X, Yang Y, Pan XY, Wang Q, Wu YT, Huang C, Meng XM, Li J. SENP2 alleviates CCl4-induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion. Toxicol Lett 2018;289:86-98. [PMID: 29535048 DOI: 10.1016/j.toxlet.2018.03.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
120 Santoro R, Mangia A. Progress in promising anti-fibrotic therapies. Expert Rev Gastroenterol Hepatol 2019;13:1145-52. [PMID: 31692390 DOI: 10.1080/17474124.2019.1688659] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
121 Fujiwara N, Hoshida Y. Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis. Semin Liver Dis 2019;39:153-62. [PMID: 30912093 DOI: 10.1055/s-0039-1681031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
122 Kubota N, Fujiwara N, Hoshida Y. Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk. J Clin Med 2020;9:E3843. [PMID: 33256232 DOI: 10.3390/jcm9123843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Tadokoro T, Morishita A, Masaki T. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. Int J Mol Sci 2021;22:8139. [PMID: 34360904 DOI: 10.3390/ijms22158139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Zhang P, Gan Z, Tang L, Zhou L, Huang X, Wang J. Exosomes from microRNA-145-5p-modified HUCB-MSCs attenuate CCl4-induced hepatic fibrosis via down-regulating FSCN1 expression. Life Sci 2021;:119404. [PMID: 33794251 DOI: 10.1016/j.lfs.2021.119404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Yan L, Messner CJ, Zhang X, Suter-Dick L. Assessment of fibrotic pathways induced by environmental chemicals using 3D-human liver microtissue model. Environ Res 2021;194:110679. [PMID: 33387535 DOI: 10.1016/j.envres.2020.110679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
126 Choi JH, Kim SM, Lee GH, Jin SW, Lee HS, Chung YC, Jeong HG. Platyconic Acid A, Platycodi Radix-Derived Saponin, Suppresses TGF-1-induced Activation of Hepatic Stellate Cells via Blocking SMAD and Activating the PPAR Signaling Pathway. Cells 2019;8:E1544. [PMID: 31795488 DOI: 10.3390/cells8121544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
127 Ganbold M, Shimamoto Y, Ferdousi F, Tominaga K, Isoda H. Antifibrotic effect of methylated quercetin derivatives on TGFβ-induced hepatic stellate cells. Biochem Biophys Rep 2019;20:100678. [PMID: 31467991 DOI: 10.1016/j.bbrep.2019.100678] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
128 Bu FT, Wang A, Zhu Y, You HM, Zhang YF, Meng XM, Huang C, Li J. LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases. Liver Int 2020;40:2612-26. [PMID: 32745314 DOI: 10.1111/liv.14629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
129 Zhou Q, Gu T, Zhang Y, Li H, Zhuansun X, Xu S, Kuang Y. Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA-455-3p through Suppression of p21-Activated Kinase-2. Biomed Res Int 2021;2021:6685605. [PMID: 33708992 DOI: 10.1155/2021/6685605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Sun S, Li Z, Huan S, Kai J, Xia S, Su Y, Ji S, Chen A, Wang S, Xu X, Shao J, Zhang F, Zhang B, Zhang Z, Zheng S. Modification of lysine deacetylation regulates curcumol-induced necroptosis through autophagy in hepatic stellate cells. Phytother Res 2022. [PMID: 35545249 DOI: 10.1002/ptr.7483] [Reference Citation Analysis]
131 Ge JY, Zheng YW, Tsuchida T, Furuya K, Isoda H, Taniguchi H, Ohkohchi N, Oda T. Hepatic stellate cells contribute to liver regeneration through galectins in hepatic stem cell niche. Stem Cell Res Ther 2020;11:425. [PMID: 32993816 DOI: 10.1186/s13287-020-01942-x] [Reference Citation Analysis]
132 Brovold M, Keller D, Soker S. Differential fibrotic phenotypes of hepatic stellate cells within 3D liver organoids. Biotechnol Bioeng 2020;117:2516-26. [PMID: 32391915 DOI: 10.1002/bit.27379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
133 Chen Q, Bao L, Lv L, Xie F, Zhou X, Zhang H, Zhang G. Schisandrin B regulates macrophage polarization and alleviates liver fibrosis via activation of PPARγ. Ann Transl Med 2021;9:1500. [PMID: 34805362 DOI: 10.21037/atm-21-4602] [Reference Citation Analysis]
134 Wang X, Gao Y, Li Y, Huang Y, Zhu Y, Lv W, Wang R, Gou L, Cheng C, Feng Z, Xie J, Tian J, Yao R. Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B/PDGFR-β pathway in hepatic stellate cells. Cell Death Dis 2020;11:458. [PMID: 32541811 DOI: 10.1038/s41419-020-2575-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
135 Ramos-tovar E, Casas-grajales S, Hernández-aquino E, Flores-beltrán RE, Galindo-gómez S, Vera-aguilar E, Diaz-ruiz A, Montes S, Camacho J, Tsutsumi V, Muriel P. Cirrhosis induced by thioacetamide is prevented by stevia. Molecular mechanisms. Journal of Functional Foods 2019;52:552-64. [DOI: 10.1016/j.jff.2018.11.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
136 Yang M, Ma F, Guan M. Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Metabolites 2021;11:320. [PMID: 34067649 DOI: 10.3390/metabo11050320] [Reference Citation Analysis]
137 Yu L, Li Y, Grisé A, Wang H. CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis. Adv Exp Med Biol 2020;1276:197-222. [PMID: 32705602 DOI: 10.1007/978-981-15-6082-8_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Zhang J, Liu Q, He J, Li Y. Novel Therapeutic Targets in Liver Fibrosis. Front Mol Biosci 2021;8:766855. [PMID: 34805276 DOI: 10.3389/fmolb.2021.766855] [Reference Citation Analysis]
139 Wang PW, Wu TH, Lin TY, Chen MH, Yeh CT, Pan TL. Characterization of the Roles of Vimentin in Regulating the Proliferation and Migration of HSCs during Hepatic Fibrogenesis. Cells 2019;8:E1184. [PMID: 31581522 DOI: 10.3390/cells8101184] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
140 Devaraj E, Roy A, Royapuram Veeraragavan G, Magesh A, Varikalam Sleeba A, Arivarasu L, Marimuthu Parasuraman B. β-Sitosterol attenuates carbon tetrachloride-induced oxidative stress and chronic liver injury in rats. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1067-75. [PMID: 31930431 DOI: 10.1007/s00210-020-01810-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
141 Shi WP, Ju D, Li H, Yuan L, Cui J, Luo D, Chen ZN, Bian H. CD147 Promotes CXCL1 Expression and Modulates Liver Fibrogenesis. Int J Mol Sci 2018;19:E1145. [PMID: 29642635 DOI: 10.3390/ijms19041145] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
142 Chen L, Zhou Q, Liu E, Zhang J, Duan L, Zhu D, Chen J, Duan Y. rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway. Parasit Vectors 2019;12:279. [PMID: 31151477 DOI: 10.1186/s13071-019-3539-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
143 Ma X, Jiang Y, Wen J, Zhao Y, Zeng J, Guo Y. A comprehensive review of natural products to fight liver fibrosis: Alkaloids, terpenoids, glycosides, coumarins and other compounds. Eur J Pharmacol 2020;888:173578. [PMID: 32976828 DOI: 10.1016/j.ejphar.2020.173578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
144 Yin F, Wang W, Mao L, Cai Q, Jiang W. Effect of Human Umbilical Cord Mesenchymal Stem Cells Transfected with HGF on TGF-β1/Smad Signaling Pathway in Carbon Tetrachloride-Induced Liver Fibrosis Rats. Stem Cells and Development 2020;29:1395-406. [DOI: 10.1089/scd.2020.0060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
145 Zeng Z, Wu Y, Cao Y, Yuan Z, Zhang Y, Zhang DY, Hasegawa D, Friedman SL, Guo J. Slit2-Robo2 signaling modulates the fibrogenic activity and migration of hepatic stellate cells. Life Sci 2018;203:39-47. [PMID: 29660433 DOI: 10.1016/j.lfs.2018.04.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
146 Zhou X, Liang Z, Qin S, Ruan X, Jiang H. Serum-derived miR-574-5p-containing exosomes contribute to liver fibrosis by activating hepatic stellate cells. Mol Biol Rep 2021. [PMID: 34843038 DOI: 10.1007/s11033-021-07008-2] [Reference Citation Analysis]
147 Shin MR, Lee JA, Kim M, Lee S, Oh M, Moon J, Nam JW, Choi H, Mun YJ, Roh SS. Gardeniae Fructus Attenuates Thioacetamide-Induced Liver Fibrosis in Mice via Both AMPK/SIRT1/NF-κB Pathway and Nrf2 Signaling. Antioxidants (Basel) 2021;10:1837. [PMID: 34829709 DOI: 10.3390/antiox10111837] [Reference Citation Analysis]
148 Lai C, Feng T, Wei L, Zhang T, Zhou G, Yang Q, Lan T, Xiang G, Yao Y, Zhou L, Huang X. Development and validation of a primate model for liver fibrosis. J Pharmacol Toxicol Methods 2019;100:106600. [PMID: 31247307 DOI: 10.1016/j.vascn.2019.106600] [Reference Citation Analysis]
149 Lei X, Liu Q, Liu Q, Cao Z, Zhang J, Kuang T, Fang Y, Liu G, Qian K, Fu J, Du H, Liu Z, Xiao Z, Li C, Xu X. Camellia oil (Camellia oleifera Abel.) attenuates CCl 4 -induced liver fibrosis via suppressing hepatocyte apoptosis in mice. Food Funct 2020;11:4582-90. [DOI: 10.1039/c9fo02258a] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
150 George J, Tsuchishima M, Tsutsumi M. Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis. Cell Death Dis 2019;10:18. [PMID: 30622238 DOI: 10.1038/s41419-018-1272-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
151 Dwivedi DK, Jena G, Kumar V. Dimethyl fumarate protects thioacetamide-induced liver damage in rats: Studies on Nrf2, NLRP3, and NF-κB. J Biochem Mol Toxicol 2020;34:e22476. [PMID: 32060995 DOI: 10.1002/jbt.22476] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
152 Li H, Ding P, Peng B, Ming YZ. Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis. Hepatobiliary Pancreat Dis Int 2021;20:207-14. [PMID: 33972160 DOI: 10.1016/j.hbpd.2021.04.007] [Reference Citation Analysis]
153 Li X, Mo N, Li Z. Ginsenosides: potential therapeutic source for fibrosis-associated human diseases. J Ginseng Res 2020;44:386-98. [PMID: 32372860 DOI: 10.1016/j.jgr.2019.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
154 Du Z, Wu T, Liu L, Luo B, Wei C. Ubiquitin specific peptidase 1 promotes hepatic fibrosis through positive regulation of CXCL1 by deubiquitinating SNAIL. Dig Liver Dis 2021:S1590-8658(21)00093-1. [PMID: 33926817 DOI: 10.1016/j.dld.2021.02.025] [Reference Citation Analysis]
155 Huang YH, Chen MH, Guo QL, Chen ZX, Chen QD, Wang XZ. Interleukin-10 induces senescence of activated hepatic stellate cells via STAT3-p53 pathway to attenuate liver fibrosis. Cell Signal 2020;66:109445. [PMID: 31730896 DOI: 10.1016/j.cellsig.2019.109445] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
156 Li X, Chen R, Kemper S, Brigstock DR. Dynamic Changes in Function and Proteomic Composition of Extracellular Vesicles from Hepatic Stellate Cells during Cellular Activation. Cells 2020;9:E290. [PMID: 31991791 DOI: 10.3390/cells9020290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
157 Cheng QN, Yang X, Wu JF, Ai WB, Ni YR. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review). Mol Med Rep 2021;23:364. [PMID: 33760176 DOI: 10.3892/mmr.2021.12003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Feng R, Du W, Lui P, Zhang J, Liu Y. CAPN2 acts as an indicator of hepatitis B virus to induce hepatic fibrosis. J Cell Biochem 2020;121:2428-36. [PMID: 31680308 DOI: 10.1002/jcb.29465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
159 Xiong Y, Wen S, Li Y, Wei Y, Fang B, Li C, Huang Q, Lin X. Comprehensive analysis of transcriptomics and metabolomics to illustrate the underlying mechanism of helenalin against hepatic fibrosis. Eur J Pharmacol 2022;:174770. [PMID: 35120860 DOI: 10.1016/j.ejphar.2022.174770] [Reference Citation Analysis]
160 Wu W, Li L, Yang J, Li P, Hu Y, Zhang G, Zhu X. Therapeutic Effect of Biejiaxiaozheng Pills on Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats through the NF-κB/Nrf2 Pathway. Gastroenterol Res Pract 2021;2021:3954244. [PMID: 34868305 DOI: 10.1155/2021/3954244] [Reference Citation Analysis]
161 Liu F, Sun C, Chen Y, Du F, Yang Y, Wu G. Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway. J Clin Transl Hepatol 2021;9:917-30. [PMID: 34966655 DOI: 10.14218/JCTH.2021.00032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Martínez-Escudé A, Pera G, Rodríguez L, Arteaga I, Expósito-Martínez C, Torán-Monserrat P, Caballería L. Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects. J Clin Med 2021;10:1350. [PMID: 33805893 DOI: 10.3390/jcm10071350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 George J, Tsuchishima M, Tsutsumi M. Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models. J Mol Med (Berl) 2020;98:1203-13. [PMID: 32666246 DOI: 10.1007/s00109-020-01950-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 He L, Yuan H, Liang J, Hong J, Qu C. Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis. PLoS One 2020;15:e0233702. [PMID: 32442221 DOI: 10.1371/journal.pone.0233702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
165 Li S, Gan L, Tian YJ, Tian Y, Fan RZ, Huang D, Yuan FY, Zhang X, Lin Y, Zhu QF, Tang GH, Yan XL, Yin S. Presegetane diterpenoids from Euphorbia sieboldiana as a new type of anti-liver fibrosis agents that inhibit TGF-β/Smad signaling pathway. Bioorg Chem 2021;114:105222. [PMID: 34375196 DOI: 10.1016/j.bioorg.2021.105222] [Reference Citation Analysis]
166 Zhang YZ, Yao JN, Zhang LF, Wang CF, Zhang XX, Gao B. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway. World J Gastroenterol 2019; 25(24): 3044-3055 [PMID: 31293340 DOI: 10.3748/wjg.v25.i24.3044] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
167 Smith-Cortinez N, Fagundes RR, Gomez V, Kong D, de Waart DR, Heegsma J, Sydor S, Olinga P, de Meijer VE, Taylor CT, Bank R, Paulusma CC, Faber KN. Collagen release by human hepatic stellate cells requires vitamin C and is efficiently blocked by hydroxylase inhibition. FASEB J 2021;35:e21219. [PMID: 33236467 DOI: 10.1096/fj.202001564RR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Schinagl M, Tomin T, Gindlhuber J, Honeder S, Pfleger R, Schittmayer M, Trauner M, Birner-Gruenberger R. Proteomic Changes of Activated Hepatic Stellate Cells. Int J Mol Sci 2021;22:12782. [PMID: 34884585 DOI: 10.3390/ijms222312782] [Reference Citation Analysis]
169 Mönkemöller V, Mao H, Hübner W, Dumitriu G, Heimann P, Levy G, Huser T, Kaltschmidt B, Kaltschmidt C, Øie CI. Primary rat LSECs preserve their characteristic phenotype after cryopreservation. Sci Rep 2018;8:14657. [PMID: 30279440 DOI: 10.1038/s41598-018-32103-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
170 Ramos-tovar E, Flores-beltrán RE, Galindo-gómez S, Vera-aguilar E, Diaz-ruiz A, Montes S, Camacho J, Tsutsumi V, Muriel P. Stevia rebaudiana tea prevents experimental cirrhosis via regulation of NF-κB, Nrf2, transforming growth factor beta, Smad7, and hepatic stellate cell activation: Stevia rebaudiana tea prevents experimental cirrhosis. Phytotherapy Research 2018;32:2568-76. [DOI: 10.1002/ptr.6197] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
171 Dong Z, Li S, Si L, Ma R, Bao L, Bo A. Identification lncRNA LOC102551149/miR-23a-5p pathway in hepatic fibrosis. Eur J Clin Invest 2020;50:e13243. [PMID: 32306379 DOI: 10.1111/eci.13243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
172 Karabulut D, Akin AT, Unsal M, Lekesizcan A, Ozyazgan TM, Keti DB, Yakan B, Ekebas G. L-Carnitine ameliorates the liver by regulating alpha-SMA, iNOS, HSP90, HIF-1alpha, and RIP1 expressions of CCL4-toxic rats. Iran J Basic Med Sci 2021;24:184-90. [PMID: 33953857 DOI: 10.22038/IJBMS.2020.47711.10990] [Reference Citation Analysis]
173 Qi Y, Fan L, Ran D, Xu J, Wang Y, Wu J, Zhang Z. Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. J Oncol 2021;2021:7764817. [PMID: 34691178 DOI: 10.1155/2021/7764817] [Reference Citation Analysis]
174 Ezhilarasan D. Critical role of estrogen in the progression of chronic liver diseases. Hepatobiliary & Pancreatic Diseases International 2020;19:429-34. [DOI: 10.1016/j.hbpd.2020.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
175 Li X, Shao S, Li H, Bi Z, Zhang S, Wei Y, Bai J, Zhang R, Ma X, Ma B, Zhang L, Xie C, Ning W, Zhou H, Yang C. Byakangelicin protects against carbon tetrachloride-induced liver injury and fibrosis in mice. J Cell Mol Med 2020;24:8623-35. [PMID: 32643868 DOI: 10.1111/jcmm.15493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
176 Blanco-Rivero J, Xavier FE. Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases. Curr Pharm Des 2020;26:3633-51. [PMID: 32242780 DOI: 10.2174/1381612826666200403172736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
177 Hempel F, Roderfeld M, Savai R, Sydykov A, Irungbam K, Schermuly R, Voswinckel R, Köhler K, Churin Y, Kiss L, Bier J, Pons-Kühnemann J, Roeb E. Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice. Cells 2019;8:E1210. [PMID: 31591328 DOI: 10.3390/cells8101210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
178 Masugi Y, Abe T, Tsujikawa H, Effendi K, Hashiguchi A, Abe M, Imai Y, Hino K, Hige S, Kawanaka M, Yamada G, Kage M, Korenaga M, Hiasa Y, Mizokami M, Sakamoto M. Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. Hepatol Commun 2018;2:58-68. [PMID: 29404513 DOI: 10.1002/hep4.1121] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
179 Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37-55. [PMID: 30213667 DOI: 10.1016/j.mam.2018.09.002] [Cited by in Crossref: 121] [Cited by in F6Publishing: 127] [Article Influence: 30.3] [Reference Citation Analysis]
180 Sanz-garcía C, Fernández-iglesias A, Gracia-sancho J, Arráez-aybar LA, Nevzorova YA, Cubero FJ. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021;1:3-26. [DOI: 10.3390/livers1010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
181 Liu N, Feng J, Lu X, Yao Z, Liu Q, Lv Y, Han Y, Deng J, Zhou Y. Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways. Mediators Inflamm 2019;2019:6175091. [PMID: 31467486 DOI: 10.1155/2019/6175091] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
182 Schumacher JD, Kong B, Wu J, Rizzolo D, Armstrong LE, Chow MD, Goedken M, Lee YH, Guo GL. Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development. Hepatology 2020;71:670-85. [PMID: 31206730 DOI: 10.1002/hep.30810] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
183 Athuluri-Divakar SK, Hoshida Y. Generic chemoprevention of hepatocellular carcinoma. Ann N Y Acad Sci 2019;1440:23-35. [PMID: 30221358 DOI: 10.1111/nyas.13971] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
184 Sharma S, Ghufran SM, Ghose S, Biswas S. Cytoplasmic vacuolation with endoplasmic reticulum stress directs sorafenib induced non-apoptotic cell death in hepatic stellate cells. Sci Rep 2021;11:3089. [PMID: 33542321 DOI: 10.1038/s41598-021-82381-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Li L, Zhou J, Li Q, Xu J, Qi J, Bian H. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation. Biomed Pharmacother 2018;106:83-91. [PMID: 29957470 DOI: 10.1016/j.biopha.2018.06.102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
186 Ogawa H, Kaji K, Nishimura N, Takagi H, Ishida K, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Yoshiji H. Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis. J Cell Mol Med 2021;25:4001-13. [PMID: 33609067 DOI: 10.1111/jcmm.16363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
187 Qiao JB, Fan QQ, Zhang CL, Lee J, Byun J, Xing L, Gao XD, Oh YK, Jiang HL. Hyperbranched lipoid-based lipid nanoparticles for bidirectional regulation of collagen accumulation in liver fibrosis. J Control Release 2020;321:629-40. [PMID: 32135224 DOI: 10.1016/j.jconrel.2020.02.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
188 Yoon YC, Fang Z, Lee JE, Park JH, Ryu JK, Jung KH, Hong SS. Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/ MAPK Pathway of Hepatic Stellate Cells. Biomol Ther (Seoul) 2020;28:527-36. [PMID: 32451370 DOI: 10.4062/biomolther.2020.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
189 Du X, Li H, Yang X, Li J, Xu J, Chen Y, Xu Q, Yang L, He C, Huang C, Meng X, Li J. Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis. International Immunopharmacology 2019;75:105671. [DOI: 10.1016/j.intimp.2019.05.056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
190 Lee EH, Park KI, Kim KY, Lee JH, Jang EJ, Ku SK, Kim SC, Suk HY, Park JY, Baek SY, Kim YW. Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal. Phytomedicine 2019;62:152780. [PMID: 31121384 DOI: 10.1016/j.phymed.2018.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
191 Ding W, Zhou D, Zhang S, Qian J, Yang L, Tang L. Trimetazidine inhibits liver fibrosis and hepatic stellate cell proliferation and blocks transforming growth factor-β (TGFβ)/Smad signaling in vitro and in vivo. Bioengineered 2022;13:7147-56. [PMID: 35249457 DOI: 10.1080/21655979.2022.2047403] [Reference Citation Analysis]
192 Trivella JP, Martin P, Carrion AF. Novel targeted therapies for the management of liver fibrosis. Expert Opinion on Emerging Drugs 2020;25:59-70. [DOI: 10.1080/14728214.2020.1735350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
193 Balaphas A, Meyer J, Sadoul R, Morel P, Gonelle‐gispert C, Bühler LH. Extracellular vesicles: Future diagnostic and therapeutic tools for liver disease and regeneration. Liver Int 2019;39:1801-17. [DOI: 10.1111/liv.14189] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
194 Casas-Grajales S, Alvarez-Suarez D, Ramos-Tovar E, Dayana Buendía-Montaño L, Reyes-Gordillo K, Camacho J, Tsutsumi V, Lakshman MR, Muriel P. Stevioside inhibits experimental fibrosis by down-regulating profibrotic Smad pathways and blocking hepatic stellate cell activation. Basic Clin Pharmacol Toxicol 2019;124:670-80. [PMID: 30561898 DOI: 10.1111/bcpt.13194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
195 Leilei L, Xue S, Yan L, Yuyuan L, Ying W, Wenke Q, Xuesong Y, Ming L. PM2.5-exposed hepatocytes induce hepatic stellate cells activation by releasing TGF-β1. Biochem Biophys Res Commun 2021;569:125-31. [PMID: 34243068 DOI: 10.1016/j.bbrc.2021.07.002] [Reference Citation Analysis]
196 Claveria-Cabello A, Colyn L, Uriarte I, Latasa MU, Arechederra M, Herranz JM, Alvarez L, Urman JM, Martinez-Chantar ML, Banales JM, Sangro B, Rombouts K, Oyarzabal J, Marin JJG, Berasain C, Avila MA, Fernandez-Barrena MG. Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis. Cancers (Basel) 2020;12:E3748. [PMID: 33322158 DOI: 10.3390/cancers12123748] [Reference Citation Analysis]
197 Alkhouri N, Reddy GK, Lawitz E. Oligonucleotide-Based Therapeutics: An Emerging Strategy for the Treatment of Chronic Liver Diseases. Hepatology 2021;73:1581-93. [PMID: 32978989 DOI: 10.1002/hep.31569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
198 Kim HJ, Lee Y, Fang S, Kim W, Kim HJ, Kim JW. GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress. BMB Rep 2020;53:317-22. [PMID: 32317079 [PMID: 32317079 DOI: 10.5483/bmbrep.2020.53.6.280] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
199 Chen Z, Yao L, Liu Y, Pan Z, Peng S, Wan G, Cheng J, Wang J, Cao W. Astragaloside IV regulates NF-κB-mediated cellular senescence and apoptosis of hepatic stellate cells to suppress PDGF-BB-induced activation. Exp Ther Med 2019;18:3741-50. [PMID: 31641375 DOI: 10.3892/etm.2019.8047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
200 Yang T, Yuan P, Yang Y, Liang N, Wang Q, Li J, Lu R, Zhang H, Mu J, Yan Z, Chang H. NPAS2 Contributes to Liver Fibrosis by Direct Transcriptional Activation of Hes1 in Hepatic Stellate Cells. Mol Ther Nucleic Acids 2019;18:1009-22. [PMID: 31778954 DOI: 10.1016/j.omtn.2019.10.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
201 Kholodenko IV, Kurbatov LK, Kholodenko RV, Manukyan GV, Yarygin KN. Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope? Cells 2019;8:E1127. [PMID: 31546729 DOI: 10.3390/cells8101127] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
202 Meijer EM, van Dijk CGM, Kramann R, Verhaar MC, Cheng C. Implementation of Pericytes in Vascular Regeneration Strategies. Tissue Eng Part B Rev 2021. [PMID: 33231500 DOI: 10.1089/ten.TEB.2020.0229] [Reference Citation Analysis]
203 Kim JK, Han NR, Park SM, Jegal KH, Jung JY, Jung EH, Kim EO, Kim D, Jung DH, Lee JR, Park CA, Ku SK, Cho IJ, Kim SC. Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-κB and Akt. Food Chem Toxicol 2020;135:111044. [PMID: 31830547 DOI: 10.1016/j.fct.2019.111044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
204 Kim AD, Kim SE, Leszczynska A, Kaufmann B, Reca A, Kim DJ, Feldstein AE. Dual role of neutrophils in modulating liver injury and fibrosis during development and resolution of diet-induced murine steatohepatitis. Sci Rep 2021;11:24194. [PMID: 34921208 DOI: 10.1038/s41598-021-03679-w] [Reference Citation Analysis]
205 Zhang WJ, Fang ZM, Liu WQ. NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-κB. Parasit Vectors 2019;12:29. [PMID: 30635040 DOI: 10.1186/s13071-018-3223-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
206 Ortega-Ribera M, Hunt NJ, Gracia-Sancho J, Cogger VC. The Hepatic Sinusoid in Aging and Disease: Update and Advances From the 20th Liver Sinusoid Meeting. Hepatol Commun 2020;4:1087-98. [PMID: 32626839 DOI: 10.1002/hep4.1517] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
207 Mannaerts I, Eysackers N, Anne van Os E, Verhulst S, Roosens T, Smout A, Hierlemann A, Frey O, Leite SB, van Grunsven LA. The fibrotic response of primary liver spheroids recapitulates in vivo hepatic stellate cell activation. Biomaterials 2020;261:120335. [PMID: 32891040 DOI: 10.1016/j.biomaterials.2020.120335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
208 Pu S, Li Y, Liu Q, Zhang X, Chen L, Li R, Zhang J, Wu T, Tang Q, Yang X, Zhang Z, Huang Y, Kuang J, Li H, Zou M, Jiang W, He J. Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis. Front Pharmacol 2021;12:628583. [PMID: 33679410 DOI: 10.3389/fphar.2021.628583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
209 Pan X, Ma X, Jiang Y, Wen J, Yang L, Chen D, Cao X, Peng C. A Comprehensive Review of Natural Products against Liver Fibrosis: Flavonoids, Quinones, Lignans, Phenols, and Acids. Evid Based Complement Alternat Med 2020;2020:7171498. [PMID: 33082829 DOI: 10.1155/2020/7171498] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
210 Bao Y, Pang Y, Tang S, Niu T, Guo Z, He H, Li Y, Song D. 12N-Substituted Matrinol Derivatives Inhibited the Expression of Fibrogenic Genes via Repressing Integrin/FAK/PI3K/Akt Pathway in Hepatic Stellate Cells. Molecules 2019;24:E3748. [PMID: 31627430 DOI: 10.3390/molecules24203748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
211 Al Mamun A, Akter A, Hossain S, Sarker T, Safa SA, Mustafa QG, Muhammad SA, Munir F. Role of NLRP3 inflammasome in liver disease. J Dig Dis 2020;21:430-6. [PMID: 32585073 DOI: 10.1111/1751-2980.12918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
212 Cacicedo ML, Medina-Montano C, Kaps L, Kappel C, Gehring S, Bros M. Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy. Cells 2020;9:E1985. [PMID: 32872352 DOI: 10.3390/cells9091985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
213 Hu M, Huang L. Nanomaterial Manipulation of Immune Microenvironment in the Diseased Liver. Adv Funct Mater 2018. [DOI: 10.1002/adfm.201805760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
214 Torre P, Motta BM, Sciorio R, Masarone M, Persico M. Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System. Front Med (Lausanne) 2021;8:781567. [PMID: 34957156 DOI: 10.3389/fmed.2021.781567] [Reference Citation Analysis]
215 Shan S, Liu Z, Wang S, Liu Z, Huang Z, Yang Y, Zhang C, Song F. Drp1-mediated mitochondrial fission promotes carbon tetrachloride-induced hepatic fibrogenesis in mice. Toxicology Research 2022. [DOI: 10.1093/toxres/tfac027] [Reference Citation Analysis]
216 Xing L, Chang X, Shen L, Zhang C, Fan Y, Cho C, Zhang Z, Jiang H. Progress in drug delivery system for fibrosis therapy. Asian J Pharm Sci 2021;16:47-61. [PMID: 33613729 DOI: 10.1016/j.ajps.2020.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
217 Cai X, Wang J, Wang J, Zhou Q, Yang B, He Q, Weng Q. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy. Pharmacol Res 2020;155:104720. [PMID: 32092405 DOI: 10.1016/j.phrs.2020.104720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
218 Sovaila S, Purcarea A, Gheonea D, Ionescu S, Ciurea T. Cellular Interactions in the Human Fatty Liver. J Med Life 2019;12:338-40. [PMID: 32025251 DOI: 10.25122/jml-2019-1010] [Reference Citation Analysis]
219 Conte E. Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches. Pharmacol Ther 2021;:108031. [PMID: 34774879 DOI: 10.1016/j.pharmthera.2021.108031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Abbas N, Getachew A, You K, Shah Z, Chen Y, Tao J, Hussain M, Yang F, Zhuang Y, Xu Y, Li YX. Kupffer cells mediate the recruitment of hepatic stellate cells into the localized liver damage. Biochem Biophys Res Commun 2020;529:474-9. [PMID: 32703454 DOI: 10.1016/j.bbrc.2020.06.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
221 Liang J, Yuan H, Xu L, Wang F, Bao X, Yan Y, Wang H, Zhang C, Jin R, Ma L, Zhang J, Huri L, Su X, Xiao R, Ma Y. Study on the effect of Mongolian medicine Qiwei Qinggan Powder on hepatic fibrosis through JAK2/STAT3 pathway. Biosci Biotechnol Biochem 2021;85:775-85. [PMID: 33686395 DOI: 10.1093/bbb/zbab001] [Reference Citation Analysis]
222 Cannito S, Milani C, Cappon A, Parola M, Strazzabosco M, Cadamuro M. Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies. Int J Mol Sci. 2018;19. [PMID: 30518128 DOI: 10.3390/ijms19123875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
223 Yang L, Han B, Zhang M, Wang YH, Tao K, Zhu MX, He K, Zhang ZG, Hou S. Activation of BK Channels Prevents Hepatic Stellate Cell Activation and Liver Fibrosis Through the Suppression of TGFβ1/SMAD3 and JAK/STAT3 Profibrotic Signaling Pathways. Front Pharmacol 2020;11:165. [PMID: 32210801 DOI: 10.3389/fphar.2020.00165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
224 Wang J, Ding Y, Zhou W. Albumin self-modified liposomes for hepatic fibrosis therapy via SPARC-dependent pathways. Int J Pharm 2020;574:118940. [PMID: 31830578 DOI: 10.1016/j.ijpharm.2019.118940] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
225 Li X, Li H, Zhang S, Zhang R, Li J, Wei Y, Yang C, Zhang F, Zhou H. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway. J Cell Mol Med 2021. [PMID: 34747105 DOI: 10.1111/jcmm.17039] [Reference Citation Analysis]
226 Carmona R, Barrena S, Muñoz-Chápuli R. Retinoids in Stellate Cells: Development, Repair, and Regeneration. J Dev Biol 2019;7:E10. [PMID: 31137700 DOI: 10.3390/jdb7020010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
227 Foglia B, Cannito S, Bocca C, Parola M, Novo E. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. Int J Mol Sci. 2019;20. [PMID: 31159366 DOI: 10.3390/ijms20112700] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
228 Xuan J, Xu H, Li H, Chen D, Qiu Y, Chen X, Shao M, Xia X. Extracellular Vesicles from miR-148a-5p-Enriched Bone Marrow Mesenchymal Stem Cells Relieve Hepatic Fibrosis by Targeting Smad4. Mol Biotechnol 2022. [PMID: 35006577 DOI: 10.1007/s12033-021-00441-5] [Reference Citation Analysis]
229 Cai SY, Boyer JL. The role of bile acids in cholestatic liver injury. Ann Transl Med 2021;9:737. [PMID: 33987435 DOI: 10.21037/atm-20-5110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
230 Huang X, Khoong Y, Han C, Su D, Ma H, Gu S, Li Q, Zan T. Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity? Front Physiol 2021;12:694605. [PMID: 34335301 DOI: 10.3389/fphys.2021.694605] [Reference Citation Analysis]
231 Melgar-Lesmes P, Luquero A, Parra-Robert M, Mora A, Ribera J, Edelman ER, Jiménez W. Graphene-Dendrimer Nanostars for Targeted Macrophage Overexpression of Metalloproteinase 9 and Hepatic Fibrosis Precision Therapy. Nano Lett 2018;18:5839-45. [PMID: 30096241 DOI: 10.1021/acs.nanolett.8b02498] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
232 Wang C, Liu J, Yan Y, Tan Y, Jinhui L. Role of Exosomes in Chronic Liver Disease Development and Their Potential Clinical Applications. Journal of Immunology Research 2022;2022:1-15. [DOI: 10.1155/2022/1695802] [Reference Citation Analysis]
233 Xiong J, Ni J, Chen C, Wang K. miR‑148a‑3p regulates alcoholic liver fibrosis through targeting ERBB3. Int J Mol Med 2020;46:1003-12. [PMID: 32582976 DOI: 10.3892/ijmm.2020.4655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
234 Segal-Salto M, Barashi N, Katav A, Edelshtein V, Aharon A, Hashmueli S, George J, Maor Y, Pinzani M, Haberman D, Hall A, Friedman S, Mor A. A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage. JHEP Rep 2020;2:100064. [PMID: 32039405 DOI: 10.1016/j.jhepr.2019.100064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
235 Matuszczak E, Tylicka M, Komarowska MD, Debek W, Hermanowicz A. Ubiquitin carboxy-terminal hydrolase L1 - physiology and pathology. Cell Biochem Funct 2020;38:533-40. [PMID: 32207552 DOI: 10.1002/cbf.3527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
236 Oh SH, Swiderska-Syn M, Jewell ML, Premont RT, Diehl AM. Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes. J Hepatol 2018;69:359-67. [PMID: 29758331 DOI: 10.1016/j.jhep.2018.05.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
237 Sbierski-Kind J, Mroz N, Molofsky AB. Perivascular stromal cells: Directors of tissue immune niches. Immunol Rev 2021;302:10-31. [PMID: 34075598 DOI: 10.1111/imr.12984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Tee JK, Peng F, Tan YL, Yu B, Ho HK. Magnesium Isoglycyrrhizinate Ameliorates Fibrosis and Disrupts TGF-β-Mediated SMAD Pathway in Activated Hepatic Stellate Cell Line LX2. Front Pharmacol 2018;9:1018. [PMID: 30319402 DOI: 10.3389/fphar.2018.01018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
239 Muriel P. Fighting liver fibrosis to reduce mortality associated with chronic liver diseases: The importance of new molecular targets and biomarkers. EBioMedicine 2019;40:35-6. [PMID: 30745133 DOI: 10.1016/j.ebiom.2019.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
240 Xu B, Yang Q, Tang Y, Tan Z, Fu H, Peng J, Xiang X, Gan L, Deng G, Mao Q, Xu PX, Jiang Y, Ding J. SIX1/EYA1 are novel liver damage biomarkers in chronic hepatitis B and other liver diseases. Ann Transl Med 2021;9:992. [PMID: 34277792 DOI: 10.21037/atm-21-2526] [Reference Citation Analysis]
241 Kondo R, Deguchi A, Kawata N, Suzuki Y, Yamamura H. Involvement of TREK1 channels in the proliferation of human hepatic stellate LX-2 cells. Journal of Pharmacological Sciences 2022;148:286-94. [DOI: 10.1016/j.jphs.2022.01.003] [Reference Citation Analysis]
242 Xie ZY, Wang FF, Xiao ZH, Liu SF, Lai YL, Tang SL. Long noncoding RNA XIST enhances ethanol-induced hepatic stellate cells autophagy and activation via miR-29b/HMGB1 axis. IUBMB Life 2019;71:1962-72. [PMID: 31418997 DOI: 10.1002/iub.2140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
243 Wang Q, Zhou Y, Huang J, Huang N. Structure, Function, and Pharmaceutical Ligands of 5-Hydroxytryptamine 2B Receptor. Pharmaceuticals (Basel) 2021;14:76. [PMID: 33498477 DOI: 10.3390/ph14020076] [Reference Citation Analysis]
244 Yu H, Jiang X, Dong F, Zhang F, Ji X, Xue M, Yang F, Chen J, Hu X, Bao Z. Lipid accumulation-induced hepatocyte senescence regulates the activation of hepatic stellate cells through the Nrf2-antioxidant response element pathway. Exp Cell Res 2021;405:112689. [PMID: 34107274 DOI: 10.1016/j.yexcr.2021.112689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
245 Zhang F, Xu M, Yin X, Guo H, Zhang B, Wang Y, Xiao J, Zou X, Zhang M, Zhuge Y. TWEAK promotes hepatic stellate cell migration through activating EGFR/Src and PI3K/AKT pathways. Cell Biol Int 2019. [PMID: 31498529 DOI: 10.1002/cbin.11230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
246 Ramos-tovar E, Flores-beltrán RE, Galindo-gómez S, Camacho J, Tsutsumi V, Muriel P. An aqueous extract of Stevia rebaudiana variety Morita II prevents liver damage in a rat model of cirrhosis that mimics the human disease. Annals of Hepatology 2019;18:472-9. [DOI: 10.1016/j.aohep.2018.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
247 Liang Q, Hu Y, Zhang M, Lin C, Zhang W, Li Y, Zhu P, Xue P, Chen Y, Li Q, Wang K. The T Cell Receptor Immune Repertoire Protects the Liver From Reconsitution. Front Immunol 2020;11:584979. [PMID: 33391261 DOI: 10.3389/fimmu.2020.584979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
248 Yan J, Huang H, Liu Z, Shen J, Ni J, Han J, Wang R, Lin D, Hu B, Jin L. Hedgehog signaling pathway regulates hexavalent chromium-induced liver fibrosis by activation of hepatic stellate cells. Toxicol Lett 2020;320:1-8. [PMID: 31756458 DOI: 10.1016/j.toxlet.2019.11.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
249 Wang L, Wang Y, Quan J. Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis. Hum Cell 2020;33:582-9. [PMID: 32449114 DOI: 10.1007/s13577-020-00371-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
250 Raza S, Jokl E, Pritchett J, Martin K, Su K, Simpson K, Birchall L, Mullan AF, Athwal VS, Doherty DT, Zeef L, Henderson NC, Kalra PA, Hanley NA, Piper Hanley K. SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function. Sci Signal 2021;14:eabb4282. [PMID: 33653921 DOI: 10.1126/scisignal.abb4282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
251 Cai S, Wu L, Yuan S, Liu G, Wang Y, Fang L, Xu D. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway. Eur J Pharmacol 2021;898:173982. [PMID: 33647257 DOI: 10.1016/j.ejphar.2021.173982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C, Liu X, Zhang R, Wang Y. Praziquantel ameliorates CCl4 -induced liver fibrosis in mice by inhibiting TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate cells. Br J Pharmacol 2019;176:4666-80. [PMID: 31412137 DOI: 10.1111/bph.14831] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
253 Sharawy MH, El-Awady MS, Makled MN. Protective effects of paclitaxel on thioacetamide-induced liver fibrosis in a rat model. J Biochem Mol Toxicol 2021;35:e22745. [PMID: 33749060 DOI: 10.1002/jbt.22745] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
254 Hamza AA, Mohamed MG, Lashin FM, Amin A. Dandelion prevents liver fibrosis, inflammatory response, and oxidative stress in rats. JoBAZ 2020;81. [DOI: 10.1186/s41936-020-00177-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
255 Zhou Y, Wu R, Cai FF, Zhou WJ, Lu YY, Zhang H, Chen QL, Sun MY, Su SB. Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis. Pharm Biol 2021;59:1594-606. [PMID: 34808067 DOI: 10.1080/13880209.2021.1999275] [Reference Citation Analysis]
256 Qiao M, Yang J, Zhao Y, Zhu Y, Wang X, Wang X, Hu J. Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS. Evid Based Complement Alternat Med 2020;2020:8321732. [PMID: 32148553 DOI: 10.1155/2020/8321732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
257 Hasan M, Fukuta T, Inoue S, Mori H, Kagawa M, Kogure K. Iontophoresis-mediated direct delivery of nucleic acid therapeutics, without use of carriers, to internal organs via non-blood circulatory pathways. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.01.052] [Reference Citation Analysis]
258 Kitto LJ, Henderson NC. Hepatic Stellate Cell Regulation of Liver Regeneration and Repair. Hepatol Commun 2021;5:358-70. [PMID: 33681672 DOI: 10.1002/hep4.1628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
259 Wu Y, Wang Q, Jiang MY, Huang YY, Zhu Z, Han C, Tian YJ, Zhang B, Luo HB. Discovery of Potent Phosphodiesterase-9 Inhibitors for the Treatment of Hepatic Fibrosis. J Med Chem 2021;64:9537-49. [PMID: 34142552 DOI: 10.1021/acs.jmedchem.1c00862] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Oakley F. Interrogating mechanisms of liver fibrosis with omics. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34903888 DOI: 10.1038/s41575-021-00567-6] [Reference Citation Analysis]
261 Marangoni RG, Korman B, Varga J. Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs. Curr Rheumatol Rep 2020;22:79. [PMID: 32978695 DOI: 10.1007/s11926-020-00957-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
262 Zhou L, Li Y, Liang Q, Liu J, Liu Y. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: A review. J Drug Target 2022;:1-22. [PMID: 35179094 DOI: 10.1080/1061186X.2022.2044485] [Reference Citation Analysis]
263 Liu S, Han D, Xu C, Yang F, Li Y, Zhang K, Zhao X, Zhang J, Lu T, Lu S, Shi C, Zhang R, Yang AG, Zhao A, Qin W, Yang B, Wen W. Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts. Mol Med 2022;28:37. [PMID: 35317721 DOI: 10.1186/s10020-022-00460-1] [Reference Citation Analysis]
264 Damiris K, Tafesh ZH, Pyrsopoulos N. Efficacy and safety of anti-hepatic fibrosis drugs. World J Gastroenterol 2020; 26(41): 6304-6321 [PMID: 33244194 DOI: 10.3748/wjg.v26.i41.6304] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
265 Wang ZJ, Yu H, Hao JJ, Peng Y, Yin TT, Qiu YN. PM2.5 promotes Drp1-mediated mitophagy to induce hepatic stellate cell activation and hepatic fibrosis via regulating miR-411. Exp Cell Res 2021;407:112828. [PMID: 34508745 DOI: 10.1016/j.yexcr.2021.112828] [Reference Citation Analysis]
266 Ai W, Dong L, Wang J, Li Z, Wang X, Gao J, Wu Y, An W. Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:3780-91. [DOI: 10.1016/j.bbadis.2018.09.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
267 Li Z, Zhao L, Xia Y, Chen J, Hua M, Sun Y. Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis. Molecules 2021;26:6882. [PMID: 34833975 DOI: 10.3390/molecules26226882] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
268 Li X, Zhang H, Pan L, Zou H, Miao X, Cheng J, Wu Y. Puerarin alleviates liver fibrosis via inhibition of the ERK1/2 signaling pathway in thioacetamide-induced hepatic fibrosis in rats. Exp Ther Med 2019;18:133-8. [PMID: 31258646 DOI: 10.3892/etm.2019.7534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
269 Ramot Y, Deshpande A, Morello V, Michieli P, Shlomov T, Nyska A. Microscope-Based Automated Quantification of Liver Fibrosis in Mice Using a Deep Learning Algorithm. Toxicol Pathol 2021;49:1126-33. [PMID: 33769147 DOI: 10.1177/01926233211003866] [Reference Citation Analysis]
270 Tanase DM, Gosav EM, Neculae E, Costea CF, Ciocoiu M, Hurjui LL, Tarniceriu CC, Floria M. Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options. Int J Mol Sci 2020;21:E5927. [PMID: 32824723 DOI: 10.3390/ijms21165927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
271 Azparren-Angulo M, Royo F, Gonzalez E, Liebana M, Brotons B, Berganza J, Goñi-de-Cerio F, Manicardi N, Abad-Jordà L, Gracia-Sancho J, Falcon-Perez JM. Extracellular vesicles in hepatology: Physiological role, involvement in pathogenesis, and therapeutic opportunities. Pharmacol Ther 2021;218:107683. [PMID: 32961265 DOI: 10.1016/j.pharmthera.2020.107683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
272 He J, Hong B, Bian M, Jin H, Chen J, Shao J, Zhang F, Zheng S. Docosahexaenoic acid inhibits hepatic stellate cell activation to attenuate liver fibrosis in a PPARγ-dependent manner. Int Immunopharmacol 2019;75:105816. [PMID: 31437794 DOI: 10.1016/j.intimp.2019.105816] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
273 Montesi SB, Désogère P, Fuchs BC, Caravan P. Molecular imaging of fibrosis: recent advances and future directions. J Clin Invest 2019;129:24-33. [PMID: 30601139 DOI: 10.1172/JCI122132] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 14.7] [Reference Citation Analysis]
274 Kumar S, Duan Q, Wu R, Harris EN, Su Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev 2021;:113869. [PMID: 34280515 DOI: 10.1016/j.addr.2021.113869] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
275 Filipovic B, Lukic S, Mijac D, Marjanovic-Haljilji M, Vojnovic M, Bogdanovic J, Glisic T, Filipovic N, Al Kiswani J, Djokovic A, Kapor S, Kapor S, Bukumiric Z, Starcevic A. The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:13219. [PMID: 34948020 DOI: 10.3390/ijms222413219] [Reference Citation Analysis]
276 Delgado ME, Cárdenas BI, Farran N, Fernandez M. Metabolic Reprogramming of Liver Fibrosis. Cells 2021;10:3604. [PMID: 34944111 DOI: 10.3390/cells10123604] [Reference Citation Analysis]
277 Li XQ, Ren ZX, Li K, Huang JJ, Huang ZT, Zhou TR, Cao HY, Zhang FX, Tan B. Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis. Int J Mol Sci 2018;19:E675. [PMID: 29495545 DOI: 10.3390/ijms19030675] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
278 Tricot T, Verfaillie CM, Kumar M. Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery. Cells 2022;11:442. [DOI: 10.3390/cells11030442] [Reference Citation Analysis]
279 Bestion E, Jilkova ZM, Mège JL, Novello M, Kurma K, Pour STA, Lalmanach G, Vanderlynden L, Fizanne L, Bassissi F, Rachid M, Tracz J, Boursier J, Courcambeck J, Serdjebi C, Ansaldi C, Decaens T, Halfon P, Brun S. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. Ther Adv Chronic Dis 2020;11:2040622320942042. [PMID: 32728410 DOI: 10.1177/2040622320942042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
280 Xu H, Liu L, Cong M, Liu T, Sun S, Ma H, You H, Jia J, Wang P. EGF neutralization antibodies attenuate liver fibrosis by inhibiting myofibroblast proliferation in bile duct ligation mice. Histochem Cell Biol 2020;154:107-16. [PMID: 32180004 DOI: 10.1007/s00418-020-01867-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
281 Brigstock DR. Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. Cells 2021;10:1596. [PMID: 34202136 DOI: 10.3390/cells10071596] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
282 Yang L, Li Y, Wang S, Bian X, Jiang X, Wu J, Wang K, Wang Q, Xia J, Jiang S, Zhuge A, Yuan Y, Li S, Li L. Western Diet Aggravated Carbon Tetrachloride-Induced Chronic Liver Injury by Disturbing Gut Microbiota and Bile Acid Metabolism. Mol Nutr Food Res 2021;65:e2000811. [PMID: 33458949 DOI: 10.1002/mnfr.202000811] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
283 Wang W, Li F, Lai X, Liu H, Wu S, Han Y, Shen Y. Exosomes secreted by palmitic acid-treated hepatocytes promote LX-2 cell activation by transferring miRNA-107. Cell Death Discov 2021;7:174. [PMID: 34234100 DOI: 10.1038/s41420-021-00536-7] [Reference Citation Analysis]
284 Cannito S, Novo E, Parola M. Therapeutic pro-fibrogenic signaling pathways in fibroblasts. Adv Drug Deliv Rev 2017;121:57-84. [PMID: 28578015 DOI: 10.1016/j.addr.2017.05.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
285 Patten DA, Wilkinson AL, O'Keeffe A, Shetty S. Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer. Semin Liver Dis 2021. [PMID: 34553345 DOI: 10.1055/s-0041-1733876] [Reference Citation Analysis]
286 Patel SS, Sandur A, El-Kebir M, Gaba RC, Schook LB, Schachtschneider KM. Transcriptional Profiling of Porcine HCC Xenografts Provides Insights Into Tumor Cell Microenvironment Signaling. Front Genet 2021;12:657330. [PMID: 33995488 DOI: 10.3389/fgene.2021.657330] [Reference Citation Analysis]
287 Qin R, Zhao Q, Han B, Zhu H, Peng C, Zhan G, Huang W. Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis. Front Pharmacol 2022;13:845892. [DOI: 10.3389/fphar.2022.845892] [Reference Citation Analysis]
288 Ji J, Yu Q, Dai W, Wu L, Feng J, Zheng Y, Li Y, Guo C. Apigenin Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-β1/Smad3 and p38/PPARα Pathways. PPAR Res 2021;2021:6651839. [PMID: 33574836 DOI: 10.1155/2021/6651839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
289 Zhang K, Shi Z, Zhang M, Dong X, Zheng L, Li G, Han X, Yao Z, Han T, Hong W. Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis. Cell Death Dis. 2020;11:132. [PMID: 32071306 DOI: 10.1038/s41419-020-2323-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
290 Fujiwara N, Qian T, Koneru B, Hoshida Y. Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases. Hepatol Res 2020;50:817-30. [PMID: 32323426 DOI: 10.1111/hepr.13506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
291 Chen PJ, Kuo LM, Wu YH, Chang YC, Lai KH, Hwang TL. BAY 41-2272 Attenuates CTGF Expression via sGC/cGMP-Independent Pathway in TGFβ1-Activated Hepatic Stellate Cells. Biomedicines 2020;8:E330. [PMID: 32899801 DOI: 10.3390/biomedicines8090330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
292 Fu M, Peng D, Lan T, Wei Y, Wei X. Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.01.007] [Reference Citation Analysis]
293 Wang S, Gao S, Li Y, Qian X, Luan J, Lv X. Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease. Front Cell Dev Biol 2021;9:716842. [PMID: 34386499 DOI: 10.3389/fcell.2021.716842] [Reference Citation Analysis]
294 Asada K, Kaji K, Sato S, Seki K, Shimozato N, Kawaratani H, Takaya H, Sawada Y, Nakanishi K, Furukawa M, Kitade M, Moriya K, Namisaki T, Noguchi R, Akahane T, Yoshiji H. Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2'-deoxycytidine in Hepatic Stellate Cells. Biology (Basel) 2020;9:E117. [PMID: 32503264 DOI: 10.3390/biology9060117] [Reference Citation Analysis]
295 Mai ZH, Huang Y, Huang D, Huang ZS, He ZX, Li PL, Zhang S, Weng JF, Gu WL. Reversine and herbal Xiang-Sha-Liu-Jun-Zi decoction ameliorate thioacetamide-induced hepatic injury by regulating the RelA/NF-κB/caspase signaling pathway. Open Life Sci 2020;15:696-710. [PMID: 33817258 DOI: 10.1515/biol-2020-0059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
296 Huang H, Deng Z. Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis. Biochem Biophys Res Commun. 2019;512:14-21. [PMID: 30853178 DOI: 10.1016/j.bbrc.2019.02.147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
297 Kimura T, Singh S, Tanaka N, Umemura T. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:773432. [PMID: 34938271 DOI: 10.3389/fendo.2021.773432] [Reference Citation Analysis]
298 Wang X, Seo W, Park SH, Fu Y, Hwang S, Rodrigues RM, Feng D, Gao B, He Y. MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types. Int J Biol Sci 2021;17:1153-67. [PMID: 33867837 DOI: 10.7150/ijbs.58365] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
299 Sojoodi M, Wei L, Erstad DJ, Yamada S, Fujii T, Hirschfield H, Kim RS, Lauwers GY, Lanuti M, Hoshida Y, Tanabe KK, Fuchs BC. Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma. Cancer Prev Res (Phila) 2020;13:497-508. [PMID: 32253266 DOI: 10.1158/1940-6207.CAPR-19-0383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
300 Zhang J, Chen Y, Tian Y, Chen S, Liu H. Knockdown of TRIM15 inhibits the activation of hepatic stellate cells. J Mol Histol 2021;52:839-48. [PMID: 34142270 DOI: 10.1007/s10735-021-09997-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
301 Diehl AM. Developmental Morphogens & Recovery from Alcoholic Liver Disease. Adv Exp Med Biol 2018;1032:145-51. [PMID: 30362097 DOI: 10.1007/978-3-319-98788-0_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
302 Su Q, Kim SY, Adewale F, Zhou Y, Aldler C, Ni M, Wei Y, Burczynski ME, Atwal GS, Sleeman MW, Murphy AJ, Xin Y, Cheng X. Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. iScience 2021;24:103233. [PMID: 34755088 DOI: 10.1016/j.isci.2021.103233] [Reference Citation Analysis]
303 Tao X, Zhang R, Du R, Yu T, Yang H, Li J, Wang Y, Liu Q, Zuo S, Wang X, Lazarus M, Zhou L, Wang B, Yu Y, Shen Y. EP3 enhances adhesion and cytotoxicity of NK cells toward hepatic stellate cells in a murine liver fibrosis model. J Exp Med 2022;219:e20212414. [PMID: 35420633 DOI: 10.1084/jem.20212414] [Reference Citation Analysis]
304 Yang Y, Sun M, Li W, Liu C, Jiang Z, Gu P, Li J, Wang W, You R, Ba Q, Li X, Wang H. Rebalancing TGF-β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis. Clin Transl Med 2021;11:e410. [PMID: 34323416 DOI: 10.1002/ctm2.410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
305 Wan C, Gu T, Ling J, Qin Y, Luo J, Sun L, Hua L, Zhao J, Jiang S. Perfluorooctane sulfonate aggravates CCl4-induced hepatic fibrosis via HMGB1/TLR4/Smad signaling. Environ Toxicol 2022. [PMID: 34990082 DOI: 10.1002/tox.23458] [Reference Citation Analysis]
306 Dattaroy D, Seth RK, Sarkar S, Kimono D, Albadrani M, Chandrashekaran V, Hasson FA, Singh UP, Fan D, Nagarkatti M, Nagarkatti P, Diehl AM, Chatterjee S. Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent. Eur J Pharmacol 2018;841:33-48. [PMID: 30194936 DOI: 10.1016/j.ejphar.2018.08.040] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
307 Roderburg C, Wree A, Demir M, Schmelzle M, Tacke F. The role of the innate immune system in the development and treatment of hepatocellular carcinoma. Hepat Oncol 2020;7:HEP17. [PMID: 32273975 DOI: 10.2217/hep-2019-0007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
308 Ohara M, Ohnishi S, Hosono H, Yamamoto K, Yuyama K, Nakamura H, Fu Q, Maehara O, Suda G, Sakamoto N. Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats. Stem Cells Int 2018;2018:3212643. [PMID: 30675167 DOI: 10.1155/2018/3212643] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
309 Liang Q, Zhang M, Hu Y, Zhang W, Zhu P, Chen Y, Xue P, Li Q, Wang K. Gut Microbiome Contributes to Liver Fibrosis Impact on T Cell Receptor Immune Repertoire. Front Microbiol 2020;11:571847. [PMID: 33329430 DOI: 10.3389/fmicb.2020.571847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
310 Yang H, Xie Y, Li T, Liu S, Zeng S, Wang B. A novel minimally invasive OFM technique with orthotopic transplantation of hUC-MSCs and in vivo monitoring of liver metabolic microenvironment in liver fibrosis treatment. Stem Cell Res Ther 2021;12:534. [PMID: 34627378 DOI: 10.1186/s13287-021-02599-w] [Reference Citation Analysis]
311 Chen H, Gan Q, Yang C, Peng X, Qin J, Qiu S, Jiang Y, Tu S, He Y, Li S, Yang H, Tao L, Peng Y. A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis. J Transl Med 2019;17:280. [PMID: 31443720 DOI: 10.1186/s12967-019-2027-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
312 Gionfra F, De Vito P, Pallottini V, Lin HY, Davis PJ, Pedersen JZ, Incerpi S. The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer. Front Endocrinol (Lausanne) 2019;10:532. [PMID: 31543862 DOI: 10.3389/fendo.2019.00532] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
313 Park YJ, Kim DM, Jeong MH, Yu JS, So HM, Bang IJ, Kim HR, Kwon SH, Kim KH, Chung KH. (-)-Catechin-7-O-β-d-Apiofuranoside Inhibits Hepatic Stellate Cell Activation by Suppressing the STAT3 Signaling Pathway. Cells 2019;9:E30. [PMID: 31861943 DOI: 10.3390/cells9010030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
314 Lee J, Byun J, Shim G, Oh Y. Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-29186-8] [Reference Citation Analysis]
315 Zhang R, Kikuchi AT, Nakao T, Russell JO, Preziosi ME, Poddar M, Singh S, Bell AW, England SG, Monga SP. Elimination of Wnt Secretion From Stellate Cells Is Dispensable for Zonation and Development of Liver Fibrosis Following Hepatobiliary Injury. Gene Expr 2019;19:121-36. [PMID: 30236172 DOI: 10.3727/105221618X15373858350141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
316 Gibert-Ramos A, Sanfeliu-Redondo D, Aristu-Zabalza P, Martínez-Alcocer A, Gracia-Sancho J, Guixé-Muntet S, Fernández-Iglesias A. The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer. Cancers (Basel) 2021;13:5719. [PMID: 34830874 DOI: 10.3390/cancers13225719] [Reference Citation Analysis]
317 Schyman P, Printz RL, Estes SK, Boyd KL, Shiota M, Wallqvist A. Identification of the Toxicity Pathways Associated With Thioacetamide-Induced Injuries in Rat Liver and Kidney. Front Pharmacol 2018;9:1272. [PMID: 30459623 DOI: 10.3389/fphar.2018.01272] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
318 Lin CY, Adhikary P, Cheng K. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv Drug Deliv Rev 2021;174:127-39. [PMID: 33857552 DOI: 10.1016/j.addr.2021.04.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
319 Wang Q, Wei S, Zhou H, Li L, Zhou S, Shi C, Shi Y, Qiu J, Lu L. MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression. Front Cell Dev Biol 2020;8:513. [PMID: 32637414 DOI: 10.3389/fcell.2020.00513] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
320 Miranda JF, Scarinci LD, Ramos LF, Silva CM, Gonçalves LR, de Morais PF, Malaspina O, Moraes KCM. The modulatory effect of triclosan on the reversion of the activated phenotype of LX-2 hepatic stellate cells. J Biochem Mol Toxicol 2020;34:e22413. [PMID: 31714634 DOI: 10.1002/jbt.22413] [Reference Citation Analysis]
321 Zisser A, Ipsen DH, Tveden-Nyborg P. Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets? Biomedicines 2021;9:365. [PMID: 33807461 DOI: 10.3390/biomedicines9040365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
322 Flessa C, Kyrou I, Nasiri‐ansari N, Kaltsas G, Kassi E, Randeva HS. Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD). J of Cellular Biochemistry. [DOI: 10.1002/jcb.30247] [Reference Citation Analysis]
323 Kong Y, Huang T, Zhang H, Zhang Q, Ren J, Guo X, Fan H, Liu L. The lncRNA NEAT1/miR-29b/Atg9a axis regulates IGFBPrP1-induced autophagy and activation of mouse hepatic stellate cells. Life Sci 2019;237:116902. [PMID: 31610195 DOI: 10.1016/j.lfs.2019.116902] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
324 Qu C, Zheng D, Li S, Liu Y, Lidofsky A, Holmes JA, Chen J, He L, Wei L, Liao Y, Yuan H, Jin Q, Lin Z, Hu Q, Jiang Y, Tu M, Chen X, Li W, Lin W, Fuchs BC, Chung RT, Hong J. Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology. 2018;68:1125-1139. [PMID: 29537660 DOI: 10.1002/hep.29881] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
325 Li S, Song F, Lei X, Li J, Li F, Tan H. hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis. Aging (Albany NY) 2020;12:11517-29. [PMID: 32584784 DOI: 10.18632/aging.103257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
326 Gu L, Zhang F, Wu J, Zhuge Y. Nanotechnology in Drug Delivery for Liver Fibrosis. Front Mol Biosci 2022;8:804396. [DOI: 10.3389/fmolb.2021.804396] [Reference Citation Analysis]
327 Sun YL, Bai T, Zhou L, Zhu RT, Wang WJ, Liang RP, Li J, Zhang CX, Gou JJ. SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial-mesenchymal transition. J Cell Physiol 2021;236:4313-29. [PMID: 33230845 DOI: 10.1002/jcp.30174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
328 Kumar P, Raeman R, Chopyk DM, Smith T, Verma K, Liu Y, Anania FA. Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway. Biochim Biophys Acta Mol Basis Dis. 2018;1864:3537-3545. [PMID: 30293572 DOI: 10.1016/j.bbadis.2018.08.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
329 Widjaja AA, Singh BK, Adami E, Viswanathan S, Dong J, D'Agostino GA, Ng B, Lim WW, Tan J, Paleja BS, Tripathi M, Lim SY, Shekeran SG, Chothani SP, Rabes A, Sombetzki M, Bruinstroop E, Min LP, Sinha RA, Albani S, Yen PM, Schafer S, Cook SA. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. Gastroenterology 2019;157:777-792.e14. [PMID: 31078624 DOI: 10.1053/j.gastro.2019.05.002] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 23.3] [Reference Citation Analysis]
330 Jia Y, Gao L, Yang X, Zhang F, Chen A, Wang S, Shao J, Tan S, Zheng S. Blockade of periostin-dependent migration and adhesion by curcumol via inhibition of nuclear factor kappa B signaling in hepatic stellate cells. Toxicology 2020;440:152475. [PMID: 32344006 DOI: 10.1016/j.tox.2020.152475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
331 Albuquerque-Souza E, Sahingur SE. Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis. Periodontol 2000 2022. [PMID: 35244954 DOI: 10.1111/prd.12427] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
332 Zheng D, Jiang Y, Qu C, Yuan H, Hu K, He L, Chen P, Li J, Tu M, Lin L, Chen H, Lin Z, Lin W, Fan J, Cheng G, Hong J. Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis. Am J Pathol 2020;190:2267-81. [PMID: 32805235 DOI: 10.1016/j.ajpath.2020.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
333 Ou Q, Weng Y, Wang S, Zhao Y, Zhang F, Zhou J, Wu X. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.Dig Dis Sci. 2018;63:3398-3408. [PMID: 30191499 DOI: 10.1007/s10620-018-5268-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
334 Chen X, Ding C, Liu W, Liu X, Zhao Y, Zheng Y, Dong L, Khatoon S, Hao M, Peng X, Zhang Y, Chen H. Abscisic acid ameliorates oxidative stress, inflammation, and apoptosis in thioacetamide-induced hepatic fibrosis by regulating the NF-кB signaling pathway in mice. Eur J Pharmacol 2021;891:173652. [PMID: 33069671 DOI: 10.1016/j.ejphar.2020.173652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
335 Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers 2021;7:6. [PMID: 33479224 DOI: 10.1038/s41572-020-00240-3] [Cited by in Crossref: 96] [Cited by in F6Publishing: 108] [Article Influence: 96.0] [Reference Citation Analysis]
336 Wu P, Luo X, Sun M, Sun B, Sun M. Synergetic regulation of kupffer cells, extracellular matrix and hepatic stellate cells with versatile CXCR4-inhibiting nanocomplex for magnified therapy in liver fibrosis. Biomaterials 2022;284:121492. [PMID: 35395456 DOI: 10.1016/j.biomaterials.2022.121492] [Reference Citation Analysis]
337 Jiang QQ, Liu BB, Xu KS. New insights into BMP9 signaling in liver diseases. Mol Cell Biochem 2021;476:3591-600. [PMID: 34019202 DOI: 10.1007/s11010-021-04182-6] [Reference Citation Analysis]
338 Qiu YN, Wang GH, Zhou F, Hao JJ, Tian L, Guan LF, Geng XK, Ding YC, Wu HW, Zhang KZ. PM2.5 induces liver fibrosis via triggering ROS-mediated mitophagy. Ecotoxicol Environ Saf. 2019;167:178-187. [PMID: 30336408 DOI: 10.1016/j.ecoenv.2018.08.050] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
339 Cao Y, Mai W, Li R, Deng S, Li L, Zhou Y, Qin Q, Zhang Y, Zhou X, Han M, Liang P, Yan Y, Hao Y, Xie W, Yan J, Zhu L. Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2/EP4 pathway. Cell Mol Life Sci 2022;79:303. [PMID: 35588334 DOI: 10.1007/s00018-022-04319-w] [Reference Citation Analysis]
340 Zhou IY, Catalano OA, Caravan P. Advances in functional and molecular MRI technologies in chronic liver diseases. J Hepatol 2020;73:1241-54. [PMID: 32585160 DOI: 10.1016/j.jhep.2020.06.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
341 Li Y, Wang G, Liu J, Ouyang L. Quinolizidine alkaloids derivatives from Sophora alopecuroides Linn: Bioactivities, structure-activity relationships and preliminary molecular mechanisms. Eur J Med Chem 2020;188:111972. [PMID: 31884408 DOI: 10.1016/j.ejmech.2019.111972] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
342 Zhao B, Li S, Guo Z, Chen Z, Zhang X, Xu C, Chen J, Wei C. Dopamine receptor D2 inhibition alleviates diabetic hepatic stellate cells fibrosis by regulating the TGF-β1/Smads and NFκB pathways. Clin Exp Pharmacol Physiol 2021;48:370-80. [PMID: 33179312 DOI: 10.1111/1440-1681.13437] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
343 Zhou JC, Wang JL, Ren HZ, Shi XL. Autophagy plays a double-edged sword role in liver diseases. J Physiol Biochem 2021. [PMID: 34657993 DOI: 10.1007/s13105-021-00844-7] [Reference Citation Analysis]
344 Wang Y, Wang W, Wang M, Shi J, Jia X, Dang S, Granito A. A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-15. [DOI: 10.1155/2022/5389044] [Reference Citation Analysis]
345 Zhou QY, Yang HM, Liu JX, Xu N, Li J, Shen LP, Zhang YZ, Koda S, Zhang BB, Yu Q, Chen JX, Zheng KY, Yan C. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7. Parasit Vectors 2021;14:472. [PMID: 34521449 DOI: 10.1186/s13071-021-04972-3] [Reference Citation Analysis]
346 Sakaguchi T, Kono Y, Itaba N, Morimoto M, Isomoto H, Shiota G. Identification of a Novel Deactivating Small-Molecule Compound for Fibrogenic Hepatic Stellate Cells. Yonago Acta Med 2020;63:79-87. [PMID: 32158337 DOI: 10.33160/yam.2020.02.013] [Reference Citation Analysis]
347 Wang Y, Yan D. Plantamajoside exerts antifibrosis effects in the liver by inhibiting hepatic stellate cell activation. Exp Ther Med 2019;18:2421-8. [PMID: 31555353 DOI: 10.3892/etm.2019.7843] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
348 Ghufran H, Azam M, Mehmood A, Butt H, Riazuddin S. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment. Exp Mol Pathol 2021;123:104715. [PMID: 34699901 DOI: 10.1016/j.yexmp.2021.104715] [Reference Citation Analysis]
349 Li JJ, Jiang HC, Wang A, Bu FT, Jia PC, Zhu S, Zhu L, Huang C, Li J. Hesperetin derivative-16 attenuates CCl4-induced inflammation and liver fibrosis by activating AMPK/SIRT3 pathway. Eur J Pharmacol 2022;915:174530. [PMID: 34902361 DOI: 10.1016/j.ejphar.2021.174530] [Reference Citation Analysis]
350 Wang Y, Mou Q, Zhu Z, Zhao L, Zhu L. MALAT1 promotes liver fibrosis by sponging miR‑181a and activating TLR4‑NF‑κB signaling. Int J Mol Med 2021;48:215. [PMID: 34651657 DOI: 10.3892/ijmm.2021.5048] [Reference Citation Analysis]
351 Zadorozhna M, Di Gioia S, Conese M, Mangieri D. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment. Mol Biol Rep 2020;47:2279-88. [PMID: 32040707 DOI: 10.1007/s11033-020-05290-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
352 Li J, Deng X, Bai T, Wang S, Jiang Q, Xu K. Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88-mediated NF-κB and MAPK pathways and activating the Nrf2 pathway in mice. Int Immunopharmacol 2020;88:106961. [PMID: 33182038 DOI: 10.1016/j.intimp.2020.106961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
353 Jiayuan S, Junyan Y, Xiangzhen W, Zuping L, Jian N, Baowei H, Lifang J. Gant61 ameliorates CCl4-induced liver fibrosis by inhibition of Hedgehog signaling activity. Toxicol Appl Pharmacol 2020;387:114853. [PMID: 31816328 DOI: 10.1016/j.taap.2019.114853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
354 Ezhilarasan D. MicroRNA interplay between hepatic stellate cell quiescence and activation. Eur J Pharmacol 2020;885:173507. [PMID: 32858048 DOI: 10.1016/j.ejphar.2020.173507] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
355 Chen X, Zhang D, Wang Y, Chen K, Zhao L, Xu Y, Jiang H, Wang S. Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells. Cell Death Dis 2020;11:402. [PMID: 32467578 DOI: 10.1038/s41419-020-2613-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
356 Liang XQ, Liang J, Zhao XF, Wang XY, Deng X. Integrated network analysis of transcriptomic and protein-protein interaction data in taurine-treated hepatic stellate cells. World J Gastroenterol 2019; 25(9): 1067-1079 [PMID: 30862995 DOI: 10.3748/wjg.v25.i9.1067] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
357 Rodríguez MJ, Sabaj M, Tolosa G, Herrera Vielma F, Zúñiga MJ, González DR, Zúñiga-Hernández J. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation. Cells 2021;10:3406. [PMID: 34943914 DOI: 10.3390/cells10123406] [Reference Citation Analysis]
358 Zhao XM, Zhang J, Liang YN, Niu YC. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats. Dig Dis Sci 2020;65:2925-36. [PMID: 31900718 DOI: 10.1007/s10620-019-06017-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
359 Wu Y, Min J, Ge C, Shu J, Tian D, Yuan Y, Zhou D. Interleukin 22 in Liver Injury, Inflammation and Cancer. Int J Biol Sci 2020;16:2405-13. [PMID: 32760208 DOI: 10.7150/ijbs.38925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
360 Qin R, Huang W, Huang Y, Zhang Z, Su Y, Chen S, Wang H. lncRNA MEG3 modulates hepatic stellate cell activation by sponging miR‑145 to regulate PPARγ. Mol Med Rep 2022;25:3. [PMID: 34738631 DOI: 10.3892/mmr.2021.12519] [Reference Citation Analysis]
361 Amin NB, Carvajal-Gonzalez S, Purkal J, Zhu T, Crowley C, Perez S, Chidsey K, Kim AM, Goodwin B. Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis. Sci Transl Med. 2019;11. [PMID: 31776293 DOI: 10.1126/scitranslmed.aav9701] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
362 Islam MM, Poly TN, Walther BA, Yang HC, Jack Li YC. Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies. Cancers (Basel) 2020;12:E671. [PMID: 32183029 DOI: 10.3390/cancers12030671] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
363 Burra P, Zanetto A, Germani G. Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma. Cancers (Basel) 2018;10:E46. [PMID: 29425151 DOI: 10.3390/cancers10020046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
364 Quenum AJI, Shukla A, Rexhepi F, Cloutier M, Ghosh A, Kufer TA, Ramanathan S, Ilangumaran S. NLRC5 Deficiency Deregulates Hepatic Inflammatory Response but Does Not Aggravate Carbon Tetrachloride-Induced Liver Fibrosis. Front Immunol 2021;12:749646. [PMID: 34712238 DOI: 10.3389/fimmu.2021.749646] [Reference Citation Analysis]
365 Wagner J, Fillebeen C, Haliotis T, Charlebois E, Katsarou A, Mui J, Vali H, Pantopoulos K. Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet. PLoS One 2019;14:e0221455. [PMID: 31442254 DOI: 10.1371/journal.pone.0221455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
366 Wang WM, Xu XS, Miao CM. Kupffer Cell-Derived TNF-α Triggers the Apoptosis of Hepatic Stellate Cells through TNF-R1/Caspase 8 due to ER Stress. Biomed Res Int 2020;2020:8035671. [PMID: 32802876 DOI: 10.1155/2020/8035671] [Reference Citation Analysis]
367 Cotovio JP, Fernandes TG. Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications. Bioengineering (Basel) 2020;7:E36. [PMID: 32283585 DOI: 10.3390/bioengineering7020036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
368 Ma X, Zhang W, Jiang Y, Wen J, Wei S, Zhao Y. Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases-A Mini Review. Front Pharmacol 2020;11:531. [PMID: 32410996 DOI: 10.3389/fphar.2020.00531] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
369 Calcagno DM, Chu A, Gaul S, Taghdiri N, Toomu A, Leszczynska A, Kaufmann B, Papouchado B, Wree A, Geisler L, Hoffman HM, Feldstein AE, King KR. NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH. Hepatology 2022. [PMID: 34997987 DOI: 10.1002/hep.32320] [Reference Citation Analysis]
370 Liao YJ, Wang YH, Wu CY, Hsu FY, Chien CY, Lee YC. Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl4 and TAA-Induced Liver Fibrosis in Mice. Int J Mol Sci 2021;22:2934. [PMID: 33805788 DOI: 10.3390/ijms22062934] [Reference Citation Analysis]
371 Krenkel O, Hundertmark J, Ritz TP, Weiskirchen R, Tacke F. Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis. Cells 2019;8:E503. [PMID: 31137713 DOI: 10.3390/cells8050503] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 19.0] [Reference Citation Analysis]
372 Zhang J, Wang H, Yao L, Zhao P, Wu X. MiR-34a promotes fibrosis of hepatic stellate cells via the TGF-β pathway. Ann Transl Med 2021;9:1520. [PMID: 34790726 DOI: 10.21037/atm-21-5005] [Reference Citation Analysis]
373 Nishikawa K, Osawa Y, Kimura K. Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs. Int J Mol Sci 2018;19:E3103. [PMID: 30308992 DOI: 10.3390/ijms19103103] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
374 Salva-Pastor N, Chávez-Tapia NC, Uribe M, Nuño-Lámbarri N. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. J Steroid Biochem Mol Biol 2019;194:105445. [PMID: 31381969 DOI: 10.1016/j.jsbmb.2019.105445] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
375 Li Y, Zhang T, Liu Q, Zhang J, Li R, Pu S, Wu T, Ma L, He J. Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis. Int J Nanomedicine 2019;14:3943-53. [PMID: 31239664 DOI: 10.2147/IJN.S202821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
376 Ahmadi A, Niknahad H, Li H, Mobasheri A, Manthari RK, Azarpira N, Mousavi K, Khalvati B, Zhao Y, Sun J, Zong Y, Ommati MM, Heidari R. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity. Toxicol Lett 2021;349:12-29. [PMID: 34089816 DOI: 10.1016/j.toxlet.2021.05.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
377 Zhou G, Li C, Zhan Y, Zhang R, Lv B, Geng W, Zheng J. Pinostilbene hydrate suppresses hepatic stellate cell activation via inhibition of miR-17-5p-mediated Wnt/β-catenin pathway. Phytomedicine 2020;79:153321. [PMID: 32919323 DOI: 10.1016/j.phymed.2020.153321] [Reference Citation Analysis]
378 Yan L, Zhang X, Fu J, Liu Q, Lei X, Cao Z, Zhang J, Shao Y, Tong Q, Qin W, Liu X, Liu C, Liu Z, Li Z, Lu J, Xu X. Inhibition of the transient receptor potential vanilloid 3 channel attenuates carbon tetrachloride-induced hepatic fibrosis. Biochem Biophys Res Commun 2021;558:86-93. [PMID: 33906111 DOI: 10.1016/j.bbrc.2021.04.065] [Reference Citation Analysis]
379 Zhou MY, Cheng ML, Huang T, Hu RH, Zou GL, Li H, Zhang BF, Zhu JJ, Liu YM, Liu Y, Zhao XK. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells. World J Gastroenterol 2021; 27(40): 6908-6926 [PMID: 34790014 DOI: 10.3748/wjg.v27.i40.6908] [Reference Citation Analysis]
380 Villar-Lorenzo A, Rada P, Rey E, Marañón P, Arroba AI, Santamaría B, Sáiz J, Rupérez FJ, Barbas C, García-Monzón C, Valverde ÁM, González-Rodríguez Á. Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury. Dis Model Mech 2019;12:dmm038810. [PMID: 31262748 DOI: 10.1242/dmm.038810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
381 Li R, Li Z, Feng Y, Yang H, Shi Q, Tao Z, Cheng J, Lu X. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis. Apoptosis 2020;25:105-19. [DOI: 10.1007/s10495-019-01583-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
382 Casals C, García-fojeda B, Minutti CM. Soluble defense collagens: Sweeping up immune threats. Molecular Immunology 2019;112:291-304. [DOI: 10.1016/j.molimm.2019.06.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
383 Wu Y, Li Z, Wang S, Xiu A, Zhang C. Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway. Biomed Res Int 2019;2019:7932046. [PMID: 31828132 DOI: 10.1155/2019/7932046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
384 Li Z, Wang Z, Dong F, Shi W, Dai W, Zhao J, Li Q, Fang ZE, Ren L, Liu T, Wei Z, Mou W, Lin L, Yang Y, Xiao X, Ma L, Bai Z. Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways. Front Pharmacol 2021;12:745561. [PMID: 34675811 DOI: 10.3389/fphar.2021.745561] [Reference Citation Analysis]
385 Wahlang B, McClain C, Barve S, Gobejishvili L. Role of cAMP and phosphodiesterase signaling in liver health and disease. Cell Signal 2018;49:105-15. [PMID: 29902522 DOI: 10.1016/j.cellsig.2018.06.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
386 Kawashita E, Ozaki T, Ishihara K, Kashiwada C, Akiba S. Endothelial group IVA phospholipase A2 promotes hepatic fibrosis with sinusoidal capillarization in the early stage of a non-alcoholic steatohepatitis in mice. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120355] [Reference Citation Analysis]
387 Buchl SC, Hanquier Z, Haak AJ, Thomason YM, Huebert RC, Shah VH, Maiers JL. Traf2 and NCK Interacting Kinase Is a Critical Regulator of Procollagen I Trafficking and Hepatic Fibrogenesis in Mice. Hepatol Commun 2021. [PMID: 34677004 DOI: 10.1002/hep4.1835] [Reference Citation Analysis]
388 Lee C, Kim M, Han J, Yoon M, Jung Y. Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis. Biomedicines 2021;9:1598. [PMID: 34829827 DOI: 10.3390/biomedicines9111598] [Reference Citation Analysis]
389 Wang L, Sun Y, Luo X, Han H, Yin H, Zhao B, Chen X, Yu Q, Qiu H, Yuan X. Prophylactical Low Dose Whole-Liver Irradiation Inhibited Colorectal Liver Metastasis by Regulating Hepatic Niche in Mice. Onco Targets Ther 2020;13:8451-62. [PMID: 32922035 DOI: 10.2147/OTT.S263858] [Reference Citation Analysis]
390 Long C, Xie N, Shu Y, Wu Y, He P, Zhou Y, Xiang Y, Gu J, Yang L, Wang Y. Knockout of the Cannabinoid Receptor 2 Gene Promotes Inflammation and Hepatic Stellate Cell Activation by Promoting A20/Nuclear Factor-κB (NF-κB) Expression in Mice with Carbon Tetrachloride-Induced Liver Fibrosis. Med Sci Monit 2021;27:e931236. [PMID: 34413280 DOI: 10.12659/MSM.931236] [Reference Citation Analysis]
391 Czuba LC, Wu X, Huang W, Hollingshead N, Roberto JB, Kenerson HL, Yeung RS, Crispe IN, Isoherranen N. Altered vitamin A metabolism in human liver slices corresponds to fibrogenesis. Clin Transl Sci 2021;14:976-89. [PMID: 33382909 DOI: 10.1111/cts.12962] [Reference Citation Analysis]
392 Kim SE, Park JW, Kim MJ, Jang B, Jeon YC, Kim HJ, Ishigami A, Kim HS, Suk KT, Kim DJ, Park CK, Choi EK, Jang MK. Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis. PLoS One 2018;13:e0201744. [PMID: 30071078 DOI: 10.1371/journal.pone.0201744] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
393 Shu Y, Liu X, Huang H, Wen Q, Shu J. Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells. Mol Biol Rep 2021;48:1915-24. [PMID: 33609264 DOI: 10.1007/s11033-021-06171-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
394 Pang H, Wang C, Ye J, Wang L, Zhou X, Ge X, Zhang J, Liu Q. Diallyl trisulfide plays an antifibrotic role by inhibiting the expression of Bcl‐2 in hepatic stellate cells. J Biochem & Molecular Tox. [DOI: 10.1002/jbt.23097] [Reference Citation Analysis]
395 Liu H, Zhang S, Xu S, Koroleva M, Small EM, Jin ZG. Myofibroblast-specific YY1 promotes liver fibrosis. Biochem Biophys Res Commun 2019;514:913-8. [PMID: 31084931 DOI: 10.1016/j.bbrc.2019.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
396 Ezhilarasan D. Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells. Exp Biol Med (Maywood) 2020;245:1504-12. [PMID: 32791849 DOI: 10.1177/1535370220949148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
397 Widjaja AA, Chothani SP, Cook SA. Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy. Hum Vaccin Immunother 2020;16:2357-62. [PMID: 32530750 DOI: 10.1080/21645515.2020.1761203] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
398 Shaw TJ, Rognoni E. Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease. Curr Rheumatol Rep 2020;22:33. [PMID: 32562113 DOI: 10.1007/s11926-020-00903-w] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
399 Bao YL, Wang L, Pan HT, Zhang TR, Chen YH, Xu SJ, Mao XL, Li SW. Animal and Organoid Models of Liver Fibrosis. Front Physiol 2021;12:666138. [PMID: 34122138 DOI: 10.3389/fphys.2021.666138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
400 Lee NH, Kim SJ, Hyun J. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer. Biomedicines 2021;9:347. [PMID: 33808155 DOI: 10.3390/biomedicines9040347] [Reference Citation Analysis]
401 Koch PS, Lee KH, Goerdt S, Augustin HG. Angiodiversity and organotypic functions of sinusoidal endothelial cells. Angiogenesis 2021;24:289-310. [PMID: 33745018 DOI: 10.1007/s10456-021-09780-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
402 Cheng R, Xu H, Hong Y. miR221 regulates TGF-β1-induced HSC activation through inhibiting autophagy by directly targeting LAMP2. Mol Med Rep 2021;24:777. [PMID: 34498712 DOI: 10.3892/mmr.2021.12417] [Reference Citation Analysis]
403 Chen Q, Huang J, Tong W, Gui X, Zheng J, Hu G. The geometry-dependent regulation of hepatic stellate cells by graphene oxide nanomaterials. Biochemical and Biophysical Research Communications 2022;604:179-84. [DOI: 10.1016/j.bbrc.2022.03.050] [Reference Citation Analysis]
404 Wu YY, Wu S, Li XF, Luo S, Wang A, Yin SQ, Huang C, Li J. LncRNA MEG3 reverses CCl4-induced liver fibrosis by targeting NLRC5. Eur J Pharmacol 2021;911:174462. [PMID: 34536366 DOI: 10.1016/j.ejphar.2021.174462] [Reference Citation Analysis]
405 Atorrasagasti C, Piccioni F, Borowski S, Tirado-González I, Freitag N, Cantero MJ, Bayo J, Mazzolini G, Alaniz LD, Blois SM, Garcia MG. Acceleration of TAA-Induced Liver Fibrosis by Stress Exposure Is Associated with Upregulation of Nerve Growth Factor and Glycopattern Deviations. Int J Mol Sci 2021;22:5055. [PMID: 34064584 DOI: 10.3390/ijms22105055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
406 Peng W, Cheng S, Bao Z, Wang Y, Zhou W, Wang J, Yang Q, Chen C, Wang W. Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomedicine & Pharmacotherapy 2021;137:111342. [DOI: 10.1016/j.biopha.2021.111342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
407 Tian F, Jiang T, Qi X, Zhao Z, Li B, Aibibula M, Min H, Zhang J, Liu Y, Ma X. Role of Cytokines on the Progression of Liver Fibrosis in Mice Infected with Echinococcus multilocularis. Infect Drug Resist 2021;14:5651-60. [PMID: 34992391 DOI: 10.2147/IDR.S344508] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
408 Yang JJ, She Q, Yang Y, Tao H, Li J. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis. Toxicol Lett 2018;295:325-34. [PMID: 30010033 DOI: 10.1016/j.toxlet.2018.07.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
409 Su Y, Lu S, Hou C, Ren K, Wang M, Liu X, Zhao S, Liu X. Mitigation of liver fibrosis via hepatic stellate cells mitochondrial apoptosis induced by metformin. Int Immunopharmacol 2022;108:108683. [PMID: 35344814 DOI: 10.1016/j.intimp.2022.108683] [Reference Citation Analysis]
410 Zhang J, Li Y, Liu Q, Huang Y, Li R, Wu T, Zhang Z, Zhou J, Huang H, Tang Q, Huang C, Zhao Y, Zhang G, Jiang W, Mo L, Zhang J, Xie W, He J. Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells. Hepatology 2021;73:1140-57. [PMID: 32535965 DOI: 10.1002/hep.31418] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
411 Zhang Y, Lu W, Chen X, Cao Y, Yang Z. A Bioinformatic Analysis of Correlations between Polymeric Immunoglobulin Receptor (PIGR) and Liver Fibrosis Progression. Biomed Res Int 2021;2021:5541780. [PMID: 33937393 DOI: 10.1155/2021/5541780] [Reference Citation Analysis]
412 Scheiner B, Ulbrich G, Mandorfer M, Reiberger T, Müller C, Waneck F, Trauner M, Kölblinger C, Ferlitsch A, Sieghart W, Peck-Radosavljevic M, Pinter M. Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma. United European Gastroenterol J 2019;7:850-8. [PMID: 31316789 DOI: 10.1177/2050640619840199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
413 Trivedi P, Wang S, Friedman SL. The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells. Cell Metab 2021;33:242-57. [PMID: 33232666 DOI: 10.1016/j.cmet.2020.10.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
414 Gong Y, Yang Y. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review. Life Sci 2020;256:117909. [PMID: 32512009 DOI: 10.1016/j.lfs.2020.117909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
415 Lim HK, Jeffrey GP, Ramm GA, Soekmadji C. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles. Front Cell Infect Microbiol 2020;10:587628. [PMID: 33240824 DOI: 10.3389/fcimb.2020.587628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
416 Yan J, Hu B, Shi W, Wang X, Shen J, Chen Y, Huang H, Jin L. Gli2-regulated activation of hepatic stellate cells and liver fibrosis by TGF-β signaling. Am J Physiol Gastrointest Liver Physiol 2021;320:G720-8. [PMID: 33728992 DOI: 10.1152/ajpgi.00310.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Moradi E, Jalili-Firoozinezhad S, Solati-Hashjin M. Microfluidic organ-on-a-chip models of human liver tissue. Acta Biomater 2020;116:67-83. [PMID: 32890749 DOI: 10.1016/j.actbio.2020.08.041] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
418 Wang T, Zhou X, Kuang G, Jiang R, Guo X, Wu S, Wan J, Yin L. Paeoniflorin modulates oxidative stress, inflammation and hepatic stellate cells activation to alleviate CCl4-induced hepatic fibrosis by upregulation of heme oxygenase-1 in mice. J Pharm Pharmacol 2021;73:338-46. [PMID: 33793876 DOI: 10.1093/jpp/rgaa042] [Reference Citation Analysis]
419 Cierpka R, Weiskirchen R, Asimakopoulos A. Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation. Cells 2021;10:2184. [PMID: 34571833 DOI: 10.3390/cells10092184] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
420 Zongyi Y, Xiaowu L. Immunotherapy for hepatocellular carcinoma. Cancer Letters 2020;470:8-17. [DOI: 10.1016/j.canlet.2019.12.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 43] [Article Influence: 16.5] [Reference Citation Analysis]
421 Lan Q, Ren Z, Chen Y, Cui G, Choi IC, Ung COL, Yu HH, Lee SM. Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat. Chin Med 2021;16:27. [PMID: 33726778 DOI: 10.1186/s13020-021-00434-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
422 Di Carlo SE, Peduto L. The perivascular origin of pathological fibroblasts. J Clin Invest 2018;128:54-63. [PMID: 29293094 DOI: 10.1172/JCI93558] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 14.8] [Reference Citation Analysis]
423 Zhao Z, Lin CY, Cheng K. siRNA- and miRNA-based therapeutics for liver fibrosis. Transl Res 2019;214:17-29. [PMID: 31476281 DOI: 10.1016/j.trsl.2019.07.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
424 Barry AE, Baldeosingh R, Lamm R, Patel K, Zhang K, Dominguez DA, Kirton KJ, Shah AP, Dang H. Hepatic Stellate Cells and Hepatocarcinogenesis. Front Cell Dev Biol 2020;8:709. [PMID: 32850829 DOI: 10.3389/fcell.2020.00709] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
425 van Dijk F, Hazelhoff CM, Post E, Prins GGH, Rombouts K, Poelstra K, Olinga P, Beljaars L. Design of a Gene Panel to Expose the Versatile Role of Hepatic Stellate Cells in Human Liver Fibrosis. Pharmaceutics 2020;12:E278. [PMID: 32244897 DOI: 10.3390/pharmaceutics12030278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
426 Lin Y, Lu Y, Li X. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents. J Drug Target 2020;28:129-41. [PMID: 31280623 DOI: 10.1080/1061186X.2019.1641508] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
427 Zhang H, Sun D, Wang G, Cui S, Field RA, Li J, Zang Y. Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell. Biochem Biophys Res Commun. 2019;511:387-393. [PMID: 30797555 DOI: 10.1016/j.bbrc.2019.02.065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
428 Rastogi A, Patil N, Maiwall R, Bihari C, Soshee A, Sarin SK. Second-harmonic generation (SHG) microscopy and hepatic venous pressure gradient-based validation of a novel histological staging system for alcoholic hepatitis. Virchows Arch 2021. [PMID: 33797570 DOI: 10.1007/s00428-021-03089-3] [Reference Citation Analysis]
429 Zhang Z, Wen H, Peng B, Weng J, Zeng F. Downregulated microRNA-129-5p by Long Non-coding RNA NEAT1 Upregulates PEG3 Expression to Aggravate Non-alcoholic Steatohepatitis. Front Genet 2020;11:563265. [PMID: 33574830 DOI: 10.3389/fgene.2020.563265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
430 Seo HY, Lee SH, Lee JH, Kang YN, Choi YK, Hwang JS, Park KG, Jang BK, Kim MK. Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway. Cells 2019;8:E1442. [PMID: 31739636 DOI: 10.3390/cells8111442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]